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Overview of Chapters 
 
Chapter One 
Chapter one covers an introduction and the background of the problem. It tells the reader 
the nature of the problem and the scope of the research 
 
Chapter Two 
Chapter two deal with theoretical framework of genetic resources and the associated TK. 
It addresses the need to protect TK in local African societies from being pirated by the 
western research institutions and corporations.  
 
Chapter Three 
Chapter three provides the reader with the critical analysis of the international regulations 
dealing with TK and benefit sharing. This analysis forms the basis of the need of 
effective domestic regulations in individual countries, as will be discussed in details in 
the next chapter. 
 
Chapter Four 
Chapter four deals with the analysis of the domestic regulations in selected African 
countries. This chapter will provide an in depth study of domestic regulations hence it 
will reveal to the reader how effective or not these regulations are, in curbing the problem 
under research. 
 
 
Chapter Five 
This is a concluding chapter. It will provide for the observations, recommendations to be 
adhered as a solution of the problem under research so as the local community can enjoy 
their benefit sharing. Lastly it will provide concluding remarks in winding up the thesis.  
 
 
 
vi 
  
DECLARATION 
I John Sebastian Ombella declare that, this thesis is my own work except where 
acknowledged in the text. 
 
Signed …………………………. 
John  S. Ombella 
(Student) 
Dated on this ………………..day of ………..……….2007 
vii 
CERTIFICATION 
I certify that, I have read and hereby recommend for acceptance by the University of the 
Western Cape the thesis entitled; BENEFIT SHARING FROM TRADITIONAL KNOWLEDGE 
AND INTELLECTUAL PROPERTY RIGHTS IN AFRICA: “An Analysis of 
International Regulations,” submitted in partial fulfilment of requirement of LL.M 
Degree of the University of the Western Cape. 
 
Signed …………. 
Mr. John E. Hunt 
Supervisor 
Dated on this…………………. day of ..………… 2007 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
viii 
COPYRIGHT 
No part of this research may be produced, stored in any retrieval system or transmitted in 
any form or by any means, electronics, mechanical, photocopying or otherwise without 
the prior permission of the author or the Faculty of Law and the University of the 
Western Cape in that behalf. 
 ©John .S. Ombella 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ix 
DEDICATION 
This work is dedicated to my Father Sebastian Sinato Ombella and mother Catherine d/o 
L.M.  Msaki. They brought me up, sent me to school and taught me the right way of life, 
believing in God and hold education for my liberation. Really they mean and count a lot 
in my life and always they will. 
Stay in blessings forever more. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
x 
AKNOWLEDGEMENT 
It will be a great lie which I’m not ready to share, to state that I go down this path of 
learning alone. So much so, I would like to fulfill my moral obligation by acknowledging 
my sincere gratitude to all those who in a w ay or another helped in compiling this work. 
 
I am most thankful to my supervisor Mr. John E. Hunt of Faculty of law whose constant 
constructive, valuable criticism encouragement and intellectuality enabled me to 
complete this work. His scholarly advice, comments and assistance   through various 
stages of the study cannot be ignored   
 
I also with honor acknowledge the assistance and a friendly atmosphere created to me by 
the Institute of Traditional Medicine, Muhimbili University Collage, staff specifically at the Department of Medical 
Botany, Plant breeding and Agronomy. Dr. Kayombo just to mention, his contribution was of great 
value in my thesis.  
 
I also wish my sincere appreciation for the positive educative and critical comments 
given by   the learned brother Dr. Edward Kwakwa of WIPO who was of great help in 
my research in various stages. 
 
Many thanks should be extended to Prof A. Khan and Mr. Said of Mzumbe University 
for their great contribution. They sacrificed their time in editing my thesis and gave their 
generosity in this work. 
 
To all thank you so much and the Most high has blessed you for that. 
xi 
ABSTRACT 
This thesis is written in the contemplation of the idea that, it is only through protection of
the Traditional Knowledge (TK) in African Local societies where then these societies can
rip the benefit of its commercialization and non-commercialization. 
 
It is thus centered on the emphasis that, while the African Countries are still insisting on
the need to have amendments done to the TRIPS Agreement, they should also establish
regulations in their domestic laws to protect TK from being pirated. This emphasis is 
mainly raised at this time first due to the wide spread of bio-piracy in African Local 
Societies by the Western Multinational Pharmaceutical Corporations.  
 
Also, it is a reaction against the perception held by most African Countries that, having 
no regulation protecting TK may be used as a negotiation tool in multilateral, or it may
help them to extend the time for implementation of TRIPS Agreement. This paper present
the humble idea of the researcher that, protection of TK is for the good of the African 
local societies and the specific countries in general especially in this world of
commercialization of the biological resources and development in science and
technology. 
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CHAPTER ONE 
 
1.0 INTRODUCTION AND BACKGROUND TO THE RESEARCH 
 
African societies are not only blessed to have vast unexploited natural resources, for 
example in the form of gold, fuel and forest materials, but they are also rich in knowledge 
and genetic resources that can be used to tackle a number of current global and regional 
health problems1. It is perhaps paradoxical that most of these genetic resources and 
associated knowledge base is found in the poorer communities which are relatively 
powerless from the political and economic context.2  
 
It can be argued that, if there is to be regulation on how to access and use such resources, 
then, it is the communities from which the resources originates which should derive a 
tangible benefit. As a result of the existence and availability of a rich traditional 
knowledge based, the pharmaceutical corporations and research institutions from 
developed countries sometimes venture into such communities where they appropriate 
various kinds of knowledge and associated genetic resources in order to commercialize 
knowledge. This works to the financial detriment of such societies3 and those persons 
who are the repositories of such intellectual property knowledge base. 
 
Despite the fact that the African societies managed to fight against the colonial 
exploitation of natural resources and the colonial imposition of European based systems 
                                                 
1 Gerard Bodeker ‘Indigenous Medical Knowledge, The law and Politics of Protection’, Green Collage, 
University of Oxford, (2000) where he argues that, majority of the population of most non-industrialized 
countries still relies on traditional forms of medicines for every day heath care. In many countries, up to 80-
90% of the population is in this category. Medicinal plants and to a lesser but important extent animal 
products, form the material medica of this tradition. See also Vandana Shiva, Captive minds, captive Lives, 
RFSTNRP, New Delhi, (1995) p 128, where it is stated that, Millions of housewives, birth attendants and 
herbal healers carry on village based healthy tradition. Seventy percent of health care needs in India are still 
based on traditional systems based on the use of medical plants. 
2 Dawnes R.D and Sarha A Larid, Community Registries of Biodiversity-Related Knowledge: The Role of 
Intellectual property in Managing Access and Benefit. UNCTAD Biotrade Initiative (1999) pg 1 
3Ironically, one can even say that, now the table has turn, as we experience a reverse transfer of technology 
in which it is the poor developing countries that are transferring knowledge and thus technology to the rich 
developed world. For further discussion see also, Martin Khor, (2003) IPRs and Biodiversity: Stop the 
Theft of Indigenous Knowledge, http:// www.twinside.org.sg/title2/briefing papers/Noo07.pdf (accessed 
August 5th/ 2006) 
1 
of rule, the exploitation of traditional knowledge based (TKB) is still persisting in a 
surreptitious or covert manner that is not easily perceived by most developing societies. 
This form of subtle exploitation does not leave a physical trace or even attract public 
outcry, as it is the case with other environmental problems such as deforestation. 
 
“Bio-piracy as 'a silent disease'. It is hardly detectable, it frequently does not leave 
traces and is an elusive activity perpetrated and often abetted by many well-
known multinational companies. 'Unfortunately, it does not attract the same 
media coverage or public outcry as other environmental problems, such as 
deforestation and pollutant emissions. But this silent pillage is robbing developing 
countries in Africa, Latin America and Asia of the means to finance important 
sustainable development projects, and is a powerful disincentive for their 
biodiversity conservation efforts”4. 
 
This work examined whether the current intellectual property rights (IPRs) under the 
international regulations such as the Trade Related Aspects of Intellectual Property 
Rights Agreement (TRIPS), and the Convention on Biodiversity (CBD) and domestic 
regulations in selected African countries provide sufficient protection of the traditional 
knowledge (TK) base associated with genetic resources as utilized in medical treatment 
in local African Societies. 
 
 
The research was mainly carried out to address the fact that, African societies have been 
suffering from the exploitation of their existing genetic resources and their associated 
TK by the western multinational pharmaceutical corporations5. This was so, despite the 
presence of the international regulations governing the IPRs.  The main cause of this 
                                                 
4 See, the views of the current Brazilian ambassador in London, Jose Mauricio Bustani, when he 
interviewed by the Observer newspapers of London on bio-piracy, 
http://www.gurdian.co.uk/science/story//o,htm, and 
http://www.timesnews.co.ke/29aug06/business/buns1.html (accessed 4th/December 2006) 
5  Jay McGown Out of Africa: Mysteries of Access and Benefit Sharing, Edmonds Institute and African 
Center for Biosafety (2006)  www.edmonds-institute.org (accessed 30th October 2006) 
2 
phenomenon is the growing need for biodiversity as a source of medical advances in 
addressing the emerging health problems in the world.6  
 
Traditional societies that still hold their values and ways of life have a great deal to 
contribute to current global thinking in addressing the emerging health problems 
through resorting to and commercializing local medicines and then modifying them 
with the benefit of current scientific methodologies. For commercial purposes African 
role-players may well need to enter into joint ventures with the appropriate western 
pharmaceutical corporations.  
 
“There is a growing international interest in the potential application of know 
how that indigenous people and rural communities have developed and applied 
to natural resources over generations. The problem here is that, the TK and 
practices are being accessed by non-indigenous individuals, public and both 
private researchers and, companies in both industrialized and developing 
countries for commercial purposes to the detriment of the local communities.”7
 
The further aim of this research was to explore the question whether these international 
and local regulations have addressed sufficiently the problem of bio-piracy in most 
African local societies. That is whether they have provided strict rules regulating IPR so 
as to protect the interest of the traditional African societies. Such rules may include 
invoking: 
1) The provision for proof in the governing contract of benefit sharing,  
2) A disclosure of the origin of the genetic materials used in the invention seeking 
protection under the TRIPS.8 
                                                 
6 Caroline Lase’n Di’az (2005) Intellectual Property Rights and Biological Resources: An overview of Key 
Issues and Current Debates, Foundation for International Environmental law and Development London, 
states that; A 199 study provided estimates of the size of global markets for uses of genetic resources in the 
pharmaceutical, seed, cosmetics, horticultural and Botanical Medicine Industries with figures ranging from 
US$20billioin a year in the horticultural sector, to US$300billion a year in the pharmaceuticals. See also, 
Ten Kate K and Laird S, (1999) The commercial use of Biodiversity, Earthscan, London 
7 Ibid 
8 For a long time the African countries and other least developed countries have put forward this proposal 
but they have faced an opposition from the western Countries. 
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 Despite the fact that African countries and other developing countries have raised the 
alarm on the need to have the international regulations (TRIPS) amended,9 yet in their 
proposals, they have not given the minimum standards of what should amount to benefit 
sharing10. Commissions and inquiries11 have also been established in various 
jurisdictions to deal with the problem at hand and their suggestions were all geared 
towards the concept of benefit sharing and regulation of access to the genetic resources 
by the relevant authorities in a given country.  
 
For example, John Voumard (2000), the chair of the Commonwealth Public Inquiry into 
Access to Biological resources in Commonwealth Areas had also commented on the 
need of protection of TK in efforts to realize the benefit sharing. The inquiry had, the 
terms of reference directing them to focus on equitable sharing of benefits arising from 
utilization of TK, innovations and practices in commonwealth countries. To comment 
on benefit sharing the chair had the following;  
 
“I have listened carefully to the concerns of traditional owners in 
Commonwealth areas, particularly about the misuse of their knowledge of 
biodiversity. This issue has also been the subject of many submissions and 
representations. This Inquiry has sought to come to terms with the limitations of 
the existing legal system in protecting and valuing this knowledge. I believe the 
best protection presently available for the rights of Indigenous peoples to their 
biological resources and their intellectual property can be achieved through 
                                                 
9 Graham Dutfield, TRIPS-Related Aspects of Traditional Knowledge, International law, (2001) Vol. 
33:233 “...Developing country Government increasingly complain about TK piracy by transnational 
(usually US based) corporations, and has added this to their list of reasons to be dissatisfied with TRIPS. 
Several developing country governments have gone so far as to submit official proposals to both 
organizations (WIPO and WTO)… fro measures to be taken to protect TK legally and to prevent its miss 
appropriation by industry through inappropriate use of patents …” pg 237 
10 The effect of this will be seen in the next chapter where we will see the complexities associated with the 
issue of benefit sharing. It will be seen that, the local society are always forgotten, and wherever 
remembered they are being marginalized with other stakeholders in contract of benefit sharing. See also the 
Developing Countries Propose TRIPS amendments to curb Bio-piracy, available at, 
http://www.CENTAD.ORG/TRADENEWS74.ASP;(accessed  December  1st / 2006) 
11 These commissions includes The UK Government Commission on Intellectual Property Rights, 
Commission on IPR Country case study, Institutional issues for Developing Countries, Policy making, 
Administration and Enforcement, Inquiry 
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inclusion of appropriate contractual terms. The solutions the Inquiry 
recommends are practical and, most importantly I believe, empowering for 
Indigenous communities that have leased their land to the Commonwealth.”12
 
This work also examined the effects of giving a state sovereignty over the genetic 
resources. This is a viewpoint, which is in opposition to the most commonly held and 
traditional approach, which regarded biological and genetic resources as being a 
common heritage of humankind, and, therefore freely available to all.13 It is this trend 
that the law seems to ignore. The TK that may be associated with biological genetic 
resources, and sometimes this knowledge need not be and is not in public domain. It 
may be owned by a particular individual in a given society14.  
 
The fundamental question posed by this thesis was, does the international regulations 
provide an equitable remedy to these individuals in circumstance where the IPR is 
wrongfully appropriated? This is an important consideration because the gaps existing 
in international regulations may have been the cause of some of the problems 
encountered by the local African societies in their efforts to curb the wide spread 
misappropriation which have to date generally been unsuccessful.  
 
In addressing the Intergovernmental Committee on Intellectual Property and Genetic 
Resources, Traditional Knowledge and Folklore (seventh session) one of the 
participants had the following to say,  
 
                                                 
12 See, Voumard J, Commonwealth Public Inquiry into Access to Biological Resources In Commonwealth 
Areas, EnvironmentAustralia, Canberra, 2000, 
http://www.ea.gov.au/biodiversity/science/access/inquiry/index.html, the same is also sited by Matthew 
Rimmer, in his article, Legal Protection of Indigenous Traditional Knowledge and Cultural expressions: 
Blame it on Rio: Biodiscovery, Native title and Traditional knowledge 
13 See, the Preamble of the CBD Convention which accord State sovereignty on the Biological resources, 
thus, states are recognized as owners of the biological resources hence, any access and use of the same shall 
be in accordance to the rules and regulations of the said states.  
14 Graham Dutfield, TRIPS-Related Aspects of Traditional Knowledge, Case W. Res. J. International law 
(2001) Vol. 33:233, where he says that, the presumptions that TK is always in a public domain is false and 
its widely acceptance may have negative implications on the peoples in the local communities ([in African 
Societies] emphasis added), pg 238 
5 
“Gaps in the international property system had also been identified as the critical 
element in misappropriation. However none of the legal tools 
suggested…address the problem involved the use of patent or other intellectual 
property rules.”15
 
 
As shown above, there is likelihood for gaps in the applicable international regulations.  
Such possibility demands that there should be domestic regulations in African countries 
to remedy the situation. The question is how many African Countries have in place the 
relevant regulations governing access to genetic resources? How effective or detailed 
these regulations are in protection against plunder of the genetic resources and the 
associated traditional knowledge? These questions are answered in this research in 
order to determine how far TK is protected in African countries for the betterment of 
the local societies.  
 
From the above analysis it is apparent that the need of African traditional societies in 
their own countries to protect TK against bio-piracy exists. There are a number of ways 
through which the TK in relation to medical treatment can be protected. TRIPS, for 
example allows for the sui generis16 approach for the member countries of WTO to 
protect plant and animals in their own domestic legal system.  
 
Sui generis has no uniform meaning. However it is used to denote alternative rights 
regimes for the protection of community innovations that are not protect-able under 
conventional intellectual property laws, and, in an even broader perspective, for systems 
embodying farmers' or indigenous peoples' rights17. In this context therefore, it seems to 
                                                 
15 See, Report on the Seventh Session of the Intergovernmental Committee on Intellectual Property and 
Genetic Resources, Traditional Knowledge and Folklore, held in November 2004,Geneva available at 
www.wipo.org See also issue No. 7raised in Intergovernmental Committee on Intellectual Property and 
Genetic Resources, TK and Folklore: 10th Session Geneva November 30th –December 8th, 2006 
http://www.wipo.int/edocs/mdocs/tk/en/wipo_grtkf_ic_10/wipo_grtkf_ic_10_3.pdf accessed 30th 
December 2006  
16 See article 27 (3)(b) 
17 Dan Leskien and Michael Flitner, The TRIPS Agreement and Intellectual Property Rights for Plant 
Varieties (1998) http://www.grain.org/briefings/?id=177 (accessed 15th February 2007) 
6 
be a very good approach adopted by the TRIPS agreement as the local communities in 
protecting their medicinal plants and TKB can use various approaches that suit their 
conditions. 
 
 Sui generis allows the member states to adopt any protection,18 which will be in its 
favor in protecting animals and plants that are the most used in medical treatment by the 
traditional societies.  For example, India has developed the TK digital libraries,19 which 
shall contain the lists of all TK’s held in India. This will facilitate the work of Patent 
granting authorities by providing information on the availability of the specified TK 
against which, patent can not be granted. This approach will protect both the TK and the 
medicinal plants in the sense that, no patent shall be granted in detriment of the local 
community. 
 
It is questionable whether the African traditional societies, which have not protected TK 
domestically, can challenge the registration of the patent in circumstances where patent 
ignores the TKB. These patents may either be held in international or local registries in 
developed countries.20  
 
There are a number of problems facing the African traditional societies in attempting to 
protect TK. Such challenges will be addressed as set out below. It should born in mind 
that, most African countries have signed the Convention on Biodiversity.21 However, 
the same convention does not deal with the issue of bio-piracy that occurred prior to 
that convention coming into force. That is, it has no retrospective effects. 
 
                                                 
18 Article 27 (3) (b) of TRIPS agreement provides for options on protection of plant varieties either by 
patent, or by sui generis or combination of both. 
19 See, R. A Mashelkar, Intellectual Property Rights and The Third World, Council of 
Scientific and Industrial Research, New Delhi 
20 Most of patent in pharmaceuticals are being registered with either EPO or USPTO trace their origin in 
African traditional societies, see also Out of Africa: Mysteries of Access and Benefit Sharing,  
http://www.edmounds-institute.org, (accessed  5th/Agust/2006) 
21 See annexure ‘A’ on page 13 showing the list of about 39 African countries who are signatories to the 
Convention on Biodiversity. 
7 
Furthermore, countries engaged in high level of bio-piracy are not signatories to the 
convention. Even where they are signatories they have not ratified the convention and 
its provisions cannot be enforced. For example; the US government signed the 
convention in 1992 but was not ratified by the senate since then to date.22 This existing 
situation plus many other reasons such as: 
1) Lack of information about the fact that patents held by some 
corporations trace their origin to African countries,  
2) A lack of an efficient legal institutional framework to deal with bio-
piracy. 
3) Financial difficulties as well may obstruct African Traditional 
societies from protecting TK in the manner to be recognized 
internationally. 
4) Non-disclosure of information fro the traditional healers23 
 
1.1 STATEMENT OF THE PROBLEM 
The problem was the continued use of TK from African local societies by the western 
pharmaceutical corporations for commercial purposes, without benefiting the local 
community who are the owners and the custodians. This problem is worse especially in 
African countries where the current IP regulations, both international and domestic do not 
address this problem adequately.24
 
This problem exposes the African local societies to being exploited by the developed 
countries. The exploitation takes place in both intellectual wealthy and the genetic 
resources used in medications. This is due to the scientific and technological 
advancement and capabilities to engage in research as opposed to developing African 
countries. This is very possible due to the weakness in the current international IP 
                                                 
22 Jeremy Lovell, Biodiversity and the Global crisis, 05 May 2004.   http://www.bionet-us.org/  accessed 
16th February 2007  
23 See, F K Mpanju (Patent examiner ARIPO), ARIPO’s Initiative on Traditional Knowledge and Access 
and Benefit Sharing, a workshop held in Cape Town on 19th-24th November 2006. 
24 See, An International Seminar on Systems of Protection of Traditional Knowledge was jointly organized 
in New Delhi by India and UNCTAD during 3-5 April, 2002. pg 11 
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regulations as and the lack of tight domestic rules or regulations in protection of the TK 
and associated knowledge.25  
 
The international and domestic intellectual property regulations and polices does not 
provide an answer to solving the problem of bio-piracy. Bio-piracy commonly takes 
place in developing countries by persons and corporation from the developed countries. 
Thus these regulations do not assure equal and fair benefit sharing that ought to have 
arisen from the access and use of the genetic resources and TKB. 
 
The standpoint adopted in this work was that, TK needs to be well protected both 
domestically and internationally to assure the realization of benefit sharing between its 
users and the holders. This can be achieved through inter alia; 
a) Establishing the tight domestic rules/regulations.26  These regulations have to be 
backed up with the necessary legal institutional frameworks on access and use of 
the genetic materials in these African local societies;  
b) Amending the IP rules and regulations in these African local societies at the 
national level to reflect the needs under the rules on access and use of the TK; 
c)  Amendments of the TRIPS Agreement to include the proposals given by the 
developing countries (Africa inclusive) to avoid the continuing wide-spread of 
bio-piracy in these societies; 
d)  Lastly, challenging the already pirated genetic resources and associated TK in 
view of making sure that the respective local societies will benefit out of it.  
 
1.2 HYPOTHESIS 
The aim of this work was to explore the question, whether the international and local 
IPR regulations have addressed sufficiently the problem of bio-piracy in most African 
local societies.  
                                                 
25 The current IP regulation (TRIPS) at international level is biased towards the western scientific 
knowledge, as it does not recognize the TK. 
26 These regulations need to provide a minimum benefit sharing below where by the users of TK will not be 
allowed to give the local societies in African countries. This will help to assure fair benefit sharing between 
the users who are always the corporations from developed countries with giant capital and highly skilled in 
negotiations as compared to the locals who are the holders of the TK. 
9 
  
 
1.3 OBJECTIVES OF THE RESEARCH 
This work examined the effectiveness of the current international and domestic 
intellectual property regulations in addressing the problem of bio-piracy in local 
communities in African countries.  
 
Another objective of this research was to explore the extent of protection of TK in 
selected developing countries. It is argued that, despite the fact that the developing 
countries are proposing for protection of TK at international level, they may be doing 
nothing (or very little) domestically to avoid or prohibit bio-piracy27.  
 
Moreover, this research endeavored to examine the possible challenges that local 
African societies faces in addressing the problem of bio-piracy. Lastly the researcher 
will give recommendations on how to enhance protection so as to achieve the goal of 
equal and fair benefit sharing. 
 
1.4 METHODOLOGY 
This research was conducted in analyzing the international IPR regulations TRIPS and 
CBD. Also an analysis of the selected domestic regulations and policies in some 
African local societies will be carried. Preferably, South Africa and Tanzania are the 
countries chosen by the researcher due to the following reasons: 
i) South Africa is a developed country in comparison with its counterpart 
Tanzania. This presupposes the fact that, its regulations and policies are a bit 
advanced in addressing the problem at hand. It can be said therefore that, 
South African regulations can be used as a model in comparison to what 
their fellow African countries has done. 
                                                 
27 Graham Dutfield, (2001) TRIPS-Related Aspects of Traditional Knowledge, International law Vol. 
33:233, where he argues that, many developing country governments have made determined efforts to 
promote TK protection as a TRIPS –related issue, even while they generally do very little about TK at their 
national level… pg 239 
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ii) Tanzania is a least developed country, which needs to have such regulations 
in place by learning from fellow African country subjected under the same 
threats of bio-piracy.  
 
Questionnaires were also issued in academic Institutions, which deal with the research 
in local/traditional medicines.28  
 
Lastly, a thorough study of the existing literatures in the subject of IPRs, as far as they 
are related to the use of TK was carried out in various libraries and Internet. 
 
1.6 Target Population and sample 
The targeted populations were the academic institutions, which deal with the research in 
local/traditional medicines in South Africa and Tanzania. 
 
 
1.5 SCOPE OF THE STUDY 
The research tried to survey the relevant international and domestic intellectual property 
regulations and policies in African countries. This was aimed to examine both the 
international and domestic IPR regulation in African combat the problem of bio-piracy.  
 
A comparative study was carried between two countries that were taken as the study of 
this research, these were; South Africa and Tanzania due to the above stated reasons.29 
It is only by fighting against bio-piracy when the local society can be assured of equal 
and fair benefit sharing in the utilization of genetic resources and TK.  
 
 
 
 
                                                 
28 See, The South African Herbal Science and Medicine Institute (SAHSMI) found in University of the 
Western Cape, and any other institutions carrying out the same activities. 
29 Some few references may be done in other jurisdictions in developing countries where the problem of 
bio-piracy has been dealt with, example India. 
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CHAPTER TWO 
 
2.0 MEANING OF TRADITIONAL KNOWLEDGE AND THE NEED FOR 
ITS PROTECTION 
2.1 Meaning of TK 
Every society in the world has its own ways of life distinct from the other. Such 
distinction varies from the language used by its people, the ways of dressing and even 
their social interactions. It also includes the way its people interact with environment 
surrounding them in realization of their daily needs. For example: food, shelter, medicine 
to cure their daily illness and many more.  
 
The knowledge derived from the long time experience, use of the environment 
surrounding man has a lot of value in the modern society. This knowledge gathered in all 
sphere of life and being transmitted from one generation to another in an informal way, is 
generally referred as Traditional Knowledge (TK)30. 
 
Traditional Knowledge (TK) is that (knowledge) which is held by members of distinct 
culture and/or sometimes acquired by means of inquiry peculiar to that culture and 
concerning the culture itself or the local environment in which it exist31. The nature of 
the knowledge is also diverse: it covers, for example, literary, artistic or scientific works, 
song, dance, medical treatments and practices and agricultural technologies and 
techniques32.  
 
However, one may argue that, even the western societies may have their own traditional 
ways of life. There exist a major distinction between the TK and the western knowledge. 
                                                 
30 This term is defined by the CBD Convention to mean the Knowledge, innovations and practices of 
indigenous and local communities embodying traditional life styles, as provided in note 2 of article 8(j) of 
the Convention on Biological Diversity. 
31 See, J.Mugabe, P. Kameri-Mbote et al. (2001-5) TRADITIONAL KNOWLEDGE, GENETIC 
RESOURCES AND INTELLECTUAL PROPERTY PROTECTION:  Towards a New International 
regime, IELRC Working Paper, available at, http://www.ielrc.org/content /w0105pdf  
32 See, UK Commission on Traditional Knowledge, chapter 4; Traditional Knowledge and Geographical 
Indications. 
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The distinction is based on the ways through which TK is generated, recorded and 
transmitted from generation to generations33.  
 
 It should also be born in mind that, when we refer to the term ‘Tradition’ it does not 
mean that the knowledge does not involve an inventive step. Had this been the case then 
the traditional society would not have a justification in their efforts against bio-piracy. To 
justify that TK involves an inventive step, the term “traditional” as used in TK is 
interpreted to mean, the way it is acquired and used. 
 
 In other words, the social process of learning and sharing knowledge, which is unique to 
each indigenous, culture, lies at the very heart of its ‘traditionalism’. Much of this 
knowledge is actually quite new, but it has social meaning and legal character, entirely 
unlike the knowledge indigenous peoples acquire from settlers and industrialized 
societies34.  
 
To complement on the above statement, TK is said to be the information that people in a 
given community based on experience and adaptation to a local culture and environment 
have developed over time and continue to develop. This knowledge is used to sustain the 
community and its culture and maintain the genetic resources necessary for the continued 
survival of the community35. 
                                                 
33See, Martha Johnson, Research on Traditional Environmental Knowledge: Its development and its Role, 
as cited by Graham Dutfield (2001) TRIPS-Related Aspects of Traditional Knowledge (supra) pg 241 
where he enlisted the distinctions of Traditional Environmental Knowledge from the Western Scientific 
knowledge as the former being transmitted thorough oral traditions, learned through experience, being 
based on the understanding that the elements of matter have a life force, based on data generated by 
resources users, it is mainly qualitative (where as western is mainly quantitative), it is holistic and intuitive 
in its mode of thinking (where as western science is analytical), also it is rooted in a social context that sees 
the world in terms of social and spiritual relations between all life forms and it derives its explanations of 
environmental phenomena from cumulative, collective and often spiritual experiences. See also, Vandana 
Siva (1996),  “Protecting Our Biological and Intellectual Heritage”, as cited in Peter Darhos (1999) 
International Library of Essays in Law &Legal Theory Intellectual Property, Queen Mary and Westfield 
Collage, University of London, pg 149, See also, Coenraad J. Visser; MAKING INTELLECTUAL 
PROPERTY LAWS WORK FOR TRADITIONAL KNOWLEDGE in J. Michael Finger and P. Schuler 
(Ed) (2004) Poor People’s Knowledge: Promoting Intellectual Property in Developing Countries, pg 210 
34 See, Russel Lawrence Brush Indigenous Knowledge and Biodiversity, as cited by Graham Dutfield 
(2001) TRIPS-Related Aspects of Traditional Knowledge (supra) pg 242 
35 See, Hansen, Stephen, et al (2005) Traditional Knowledge and Intellectual Property: A Hand book on 
Issues and options for Traditional Knowledge holders in Protecting Their IP and Maintain Biological 
Diversity, Washington DC, Pg 3 
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Examples of TK; 
i) The use of Hoodia cactus by the Bushmen in Africa to stave off hunger when 
they were going for long hunting activities. 
ii)  The use of tumeric in India for healing wounds, the use of plao-noi in Thailand 
for treatment of ulcers36. 
iii)  Another one includes the use of Maytenus buchanii from Shimba Hills of Kenya, 
used by Digo to cure cancerous conditions37. 
 
This research is centered on the idea that, to assure that the African local societies benefit 
from their TK, they need to protect it in various ways against any form of appropriation. 
However, TK in the current IPR regime seems to be a burning issue due to the nature of 
the existing system in IPRs. That is TK seems not to be recognized and thus not protected 
by the existing system. 
 
 This is mainly based on the facts that, in practice the two are related but the later is not 
regulated under the existing international and some domestic IPR regime. Example, 
patent may be granted to protect IPRs in a medical product where by its origin is founded 
on TK. 
 However, it is worth to know the nature and origin of IPR, before analyzing whether it 
protects TK or not. 
 
2.1 IPRs AS PRIVATE PROPERTY 
The concept underlying intellectual property rights (IPR) is that, they are granted to an 
individual as a private property. Example, when patent or copyright is granted to an 
applicant, be it a corporation or a natural person, it excludes the rest of the society 
members from claiming on the same any right in a given limited period of time in 
accordance with the granting authority. 
 
                                                 
36 Ibid pg 3-4 
37 See, John Mugabe (1999) Intellectual Property Protection and Traditional Knowledge: An Exploration in 
International Policy Discourse, Nairobi Kenya, pg 6 
14 
The concept of private property has its genesis in developed countries especially the first 
countries to undergo industrialization, England being one. The era of agrarian revolution 
in England was characterized with one major economical approach, enclosure system38.  
 
Thus, the more land one could have enclosed and utilize would have entitled him an 
exclusive ownership plus its proceeds from the rest of the community members. Despite 
the fact that the system helped England in agrarian revolution by allowing expansion of 
productive possibilities39, yet it has its set backs as it is argued that,  
 
“Enclosure was not merely unjust in itself but harmful in its consequences. It was 
a cause of economic inequality crimes and social dislocation… Among some of 
the harms/ injustices caused by the enclosure system was…the convention of the 
free holders into peasants, seasonal wage laborers, other harms were difficult to 
classify, for example the loss of form of life, disruption of traditional social 
relations and even the relationship of human being to the environment… “40
 
 Intellectual property Rights on the other hand reflects the true picture of the development 
of the concept of private property from real or tangible properties to the intangible ones41
 
Vandana Shiva,42 had also commented on enclosure of biodiversity by the current 
International IPRs Regulations where he says, 
                                                 
38 This was the system applied by the farmers during Agrarian Revolution in England where by they 
enclosed the fertile land and used it for cultivation and hence avoid a scatted farming which did not gave 
them many yields at the end of the year.  
39 This occurred due to the transfer of inefficiently managed common land into the hands of a single owner 
who could use it for effective production, it also created incentives for large scale investment allowed 
control over exploitation, and in general the resources would be used efficiently. Unless the landlord new 
the fruits of his labor would be his alone, he would not have invested in drainage scheme, purchase of 
sheep, or the rotation of crops in order to increase the yields of his acreage. 
40 Agostino A and Ashton Glenn, (2006) A Patented World? Privatization of Life and Knowledge, Fanele, 
Johannesburg, pg 20 
41 ‘…once again, things that were formerly thought to be uncommodifiable, essentially common, or outside 
the market altogether are being turned into private possession under a new kind of property regime. But this 
time the property in question is intangible, existing in database, business methods and gene 
sequences…(Agustino A supra) 
42 Vandana Shiva, (2001) Protect or Plunder? Understanding Intellectual Property Rights, Penguin Books 
India (P) Ltd, pp 44-45 
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“The enclosure of biodiversity and knowledge is the final step in a series of 
enclosures that began with the rise of colonialism. Land and forests were the first 
resources to be enclosed and converted from commons to commodities. Later, 
water resources were enclosed through dams, ground water, and mining and 
privatization schemes. Now it is the turn of biodiversity and knowledge to be 
enclosed through IPRs.” 
 
2.3 Meaning of IPR and the need to protect TK in the current IPR system 
Intellectual property rights refer to the legal rights, which result from intellectual activity 
in the industrial, scientific, literary and artistic fields. In short it can be said to mean that 
IPRs are particular aspects of property covering all things, which emanate from the 
exercise of human brain43.  
 
 International organizations such as world intellectual property organization (WIPO) and 
countries have laws to protect intellectual property generally for two main reasons;  
1) To give legal expression to the moral and economic rights of creators in their 
creations and such rights of the public in access to those creations.  
2) To promote, creativity and the dissemination and application of its results and 
to encourage (competition) fair-trading, which would contribute to economic 
and social development in the world generally44.  
  
IPRs grants rights to the owner, to produce the product, sell, even use of the same in 
exclusion of others, in a given period of time45. Historically, IPRs such as patent has been 
justified on either consequentiality or deontological grounds. As pointed out by Graham 
                                                 
43 See, Ian Walden, Preserving Biodiversity: the role of property rights; in Intellectual Property Rights and 
Biodiversity Conservation: An interdisciplinary analysis of values of medicinal Plants, (1998) Edited by 
Timothy M. Swanson p 181 
44 Samuel Wangwe, et al Institutional Issues for Developing countries IP Policy making, administration and 
enforcement- Tanzania, Economic and Social Research Foundation.  
http://www.iprcomission.org/papers/text/studypapers accessed on 18/09/06 
45 See, Caroline T Owoseni (2001) International Conference on Intellectual Property, Internet, Electronic 
Commerce and Traditional Knowledge: Challenges in the Protection Intellectual Property Rights (IPRs); A 
Nigerian Perspective, pp 2-3 
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Dutfield, 46 the consequentialist justification is that when inventors, authors, or artists, 
have an exclusive rights, to produce and sell their works, society benefits. This 
proposition is based on two assumptions. 
• First, it assumes that such a right encourages inventors to invent and 
authors to write.  
• Second, it presupposes that, .the greater the quantity of invention and 
creative works released into the public domain, the more the public benefit 
through economic or cultural enrichment or greater physical well-being.  
 
Thus, generally IPRs are rewards for inventors and artists for their contributions to the 
public good or that they are incentives that encourage creative endeavor. The 
deontological arguments are derived from consideration of rightness and wrongness. 
 
 For instance, it may be argued that using somebody’s invention or creative work without 
his or her permission is morally wrong, because it is in some way harmful to that person 
or because it is a means of unjust enrichment 
 
The most recognized and regulated IPRs under TRIPS can traditionally be divided into 
two branches, Industrial Property and Copyright. 
 
Industrial Property, which includes inventions (Patents)47, Trademarks48, Industrial 
designs49, Geographic indications of source50; and Copyright51, which includes Literary 
and Artistic works such as novels, poems and plays, films, musical works, artistic works 
such as drawings, paintings, photographs and sculptures, and architectural designs. Rights 
related to copyright include those of performing artists in their performances, producers 
of phonograms in their recordings, and those of broadcasters in their radio and television 
programs. 
                                                 
46 Graham Dutfield (200) Intellectual Property Rights, Trade and Biodiversity, Earthscan Publications Ltd, 
London, pp 18 
47 See Article 27 
48 See Article 15 
49 See Article 25 
50 See Article 22 
51 See Article 9 that govern Copyrights and related rights. 
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 Among the existing IPRs, patent is the commonest approach used by the Pharmaceutical 
Corporation from developed countries in pirating the genetic resources and the associated 
TK from the local communities. 
 
A number of authors have written on the need to protect TK in the developing world 
against the piracy. Piracy takes place by transforming TK into scientific knowledge 
experimented in laboratories; thereafter by using patent it thus acquire a different status. 
The status of such a knowledge once found in public domain change to that of a private 
right owned by an individual or a corporation. This approach is opposed to the former 
situation, where the right was owned by the indigenous society or an individual in the 
society. 
 
Martin Khor52 has pointed out the need to protect the TK and the genetic resources in 
Indigenous society. He shows the injustices that may be caused by lack of such a 
protection, to the indigenous communities, He states that,  
 
“the problem is the patenting, usually in developing countries, of ingredients and 
other substances of plants for functions and uses that have already been in the 
public domain and in practice for many years or generations. In many cases, these 
are plants or substances that have been used in developing countries. Similarly, 
protection (Including through patenting) in the developed countries is being 
granted for plant varieties, the origin of whose genetic materials are in developing 
countries” 
 
The above statement firstly, shows the appropriation of the valuable resources and the 
associated knowledge in developing countries by the developed countries.  
 
                                                 
52 IPRs and Biodiversity: Stop the Theft of Indigenous Knowledge (2003), available at, http:// 
www.twinside.org.sg, visited on, August 5th/2006 
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Secondly, it also shows how the developed countries use the existing international IPRs 
regulations in benefiting themselves from the developing countries.  
 
The author went on exposing the number of injustices that the local community will 
undergo when the developed countries have pirated the genetic resources and associated 
TK from them. 
Among the said injustices include;  
a) Firstly, the appropriation by corporations’ of local communities’ knowledge 
on biodiversity use transfers away the rights of the communities’ and become 
the private and monopoly rights of these institutions. The IP holders can make 
monopoly profits through commercializing the patented products, while the 
local communities that either developed or used the knowledge usually do not 
get any of the benefits. 
 
b)  Secondly, and even more ironic situation arises if the patented process or 
product leads to the sale of products at higher prices to developing countries 
from where the patented process or product originated.  
 
c) Thirdly, the patent owners from the developed countries can apply for similar 
patents in developing countries from where the knowledge originated. The 
local communities in the developing countries concerned would thus be 
constrained from making use of the patented process or making or selling the 
patented product.  
 
d) Another injustice that could occur is that, the patenting of biological resources 
can restrict or prevent producers from using the processes and products 
relating to traditional knowledge. 
 
 For example, a corporation that has successfully applied for patent over the use of a plant 
for certain functions (for instance, to treat some ailments) could attempt to prevent others 
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from using the plant for the same functions. Those who have been keeping and using 
Traditional knowledge could thus be restricted and discouraged.53  
 
This will have negative effects to the society on issues of access to medicine. The genetic 
resources will be highly needed by these pharmaceutical corporations hence the society 
will be denied their right to use it. Moreover, the situation will be worsened where the 
patent holder will protect its products in the country where the genetic resources were 
found. This is because the most corporations are always selling the drugs at a high price 
that is not affordable by these local societies.54  
 
It is from the above likely injustices that may be encountered by the local societies in 
developing countries, where the researcher was inspired to examine whether the existing 
international and domestic IPRs regulations address the problem of bio-piracy in African 
local societies by the said corporations.  
 
According to McGowns’ findings of cases that are suggestive of Biopiracy, “Out of 
Africa: Mysteries of Access and Benefits Sharing”55 It shows that the African local 
societies still suffer from bio-piracy. 
 
 This problem is a result of the acts of the corporations in developed countries patenting 
drugs irrespective of the fact that the drugs trace their origin in local societies in Africa. 
Worse enough these corporations had nothing in return for the use of genetic resources 
and the associated knowledge to these local societies. 
 
Among the countries mentioned to have been affected by bio-piracy in this report include 
Kenya, Namibia, Mauritius, South Africa, Angola, Botswana, Ethiopia and neighboring 
countries, Egypt, Congo (Brazzaville) and Central and West Africa56. 
                                                 
53 IPRs and Biodiversity: Stop the Theft of Indigenous Knowledge (2003), pg 2, available at, 
http://www.twnside.org.sg, visited on August 5th/2006  
54 These drugs may be the result of the use of genetic resources and TK from the same local societies in 
African countries. 
55 Available at http;//www.edmounds-institute.org visited on August 5th /2006 
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 In summary, this report exposes and condemns the appropriation of the African genetic 
resources by the corporations in developed countries. It went further showing that it is not 
only the biodiversity in medicinal plants but also in other sectors. It is stated that, 
 
“When you look at what has been taken in the recent past from Egypt to South 
Africa, it runs the gamut (range) from biodiversity used for medicines to 
biodiversity for agriculture, horticulture, cosmetics, and industrial purposes. It is 
unbelievable how much has been taken without a public accounting and probably 
without any permission from the communities and peoples involved…57” 
 
Moreover, the report tries to establish how hard the local societies in   developing 
countries can find it to prove the case of bio-piracy. This is so, despite the fact that bio-
piracy   is widely spread in Africa. This happens especially where the African local 
societies have no any law or regulations governing access to the genetic resources and the 
TK associated to it.58 The situation shows the need to have TK protected in both 
international and domestic level for the local societies to benefit from it. 
 
A famous writer on Biodiversity issues, Vandana Shiva analyzed59 two paradigms 
existing in two groups who are all interested in biodiversity. These groups are the local 
societies whose survivals and sustenance is directly linked to the local biodiversity 
                                                                                                                                                 
56 Ibid, See, Chee Yorke Hoeng (2006) New Report points to widespread Biopiracy in Africa, available at, 
http://biosafety-info.net/file_dir/16176166044226dd411185.doc visited on August 5th /2006  
57 See Mariam Mayet (Executive Director of the African Centre for Biosafety) as quoted by Chee Y. Hoeng 
in his article cited above 
58 See the comments by the Edmounds Institute President/director Beth Burrows as cited by Chee Y. 
Hoeng, where e he said; “It’s not easy to prove bio-piracy. Where contracts (benefit sharing contracts 
between the local societies and the foreign user of the genetic resources and associated knowledge.) are not 
published and national rules of access and benefit sharing may not exist or are not attended to by bio-
prospectors, or the companies and institutions they represent, it is difficult to verify claims of theft, even 
when you catch the thieves with the booty in hand…or in their patent portfolios…” 
59 See Drahos Peter (1999) The International Library of Essays in Law& Legal Theory, Second Series; 
Intellectual Property, Dartmouth Publishing Company Ltd, England, pp 141-143 
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utilization and conservation, example, the use of herbal medicines in carrying on village 
healthy tradition (or even spiritual well being).60  
 
Another group is formed of the commercial interests whose profits are linked to 
utilization of global biodiversity for production of inputs, into large scale, homogeneous, 
uniform, centralized, and global production systems. It represents the group that view 
biodiversity as merely raw materials for the production of commodities and for 
maximization of profits. 
 
The views of the later group represent the corporations from the developed world. These 
corporations engage themselves in pirating the genetic resources and associated 
knowledge from the developing countries for maximization of profit through patent. 
 
The patents granted to these corporations are in ignorance of obvious knowledge and 
practices of these local societies in African countries. This shows a need to have clear 
regulations, and legal institutional framework in both international and local spheres in 
curbing the problem of bio-piracy. 
  
The need of effective protection of TK against the pirating corporations is much more 
needed especially in this world of scientific and technological development in developed 
countries. This is because, apart from the said corporation pirating the biological 
resources, it is possible today to bring out new products or find out new use of existing 
products based on TK utilizing the technological developments in the field of 
biotechnology.61  
                                                 
60 See also Darshan Shankar, (1994) Medicinal Plants and Biodiversity Conservation, in Biodiversity 
Conservation: Whose Resource? Whose Knowledge ed. Vandana Shiva, INTACH, New Delhi. 
61It is argued that, “…The development of new technology and the new use of traditional knowledge 
based products today is the major threat to the survival of many of these communities. The modern 
cultural industries as well as the manufacturing industries now commercially exploit the traditional 
knowledge based products using new technology without the permission and sharing of profits with the 
communities. It is possible today to bring out new products or find out new use of existing products 
based on traditional knowledge utilizing the technological developments in the field of biotechnology. 
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 African local societies having no sufficient scientific development are thus subjected to 
the problem of bio-piracy. The western corporations will thus go on appropriating due to 
either loose or no regulations in access and use of the genetic resources and TK in these 
societies. 
 
The corporations in developed countries use a number of ways to exploit the genetic 
resources in Africa local societies. Such ways include researchers of traditional medicine 
who arrive in the indigenous areas as tourists to find out how local people cure certain 
illnesses.  
 
These "tourists" then take the remedies to the developed countries and patent them as 
though they were their own inventions. It is also noted that, most of the developing 
countries do not protect the indigenous people and farmers from cultural pillaging and 
many governments see the indigenous peoples' complaints as science fiction.62 
  
 Although, the idea on the reluctance of the developing countries in recognizing the need 
to protect the biological resources and the associated TK may be time barred taking into 
account that time has passed and the issue of biopiracy s now a burning issue in 
developing countries.63 However in the year 2000, the Union of B.C. Indian Chiefs 
hosted a conference on Protecting Knowledge: Traditional Resource Rights in the New 
                                                                                                                                                 
This is proved beyond doubt particularly in the field of medicines, agriculture etc. The bio- prospecting 
help the scientists in the modern pharmaceutical research laboratories to get the know how to develop 
new products or new use of existing products.... the development of new products or new use of 
existing products enable the industries to get protection for these products through the formal 
intellectual property laws…”see, Traditional Knowledge–The changing Scenario In India, available at, 
http://www.edu.ac.uk/ahrb/publications/online/varkey.htm visited on October 9th/2006. 
62 See, Antensio Lopez, Kuna Indigenous Leader who runs an International Campaign against ‘the stealing 
of genes from native people’ in Panama, in his article titled; Indigenous People raise alarms about… 
available at, http://www.netlink.del/Zeitung/97129b.htm visited on August 5th /2006 
63 This is because the article was written in December 19th/ 1997, the situation seems to have changed since 
some countries like India and South Africa has regulations dealing with Biodiversity and associated 
knowledge 
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Millennium64 where still we see the comments rose by the participants on the need to 
protect the TK in the local communities in developing world. 
 
 In this conference one of the participants65, when asked to comment on the need of the 
colonized people to protect and renew their culture and traditions even if only a fraction 
remains, had the following to say; 
 
“as long as their heritage survives in the memories and hearts of their elders, there 
is still hope to recover what seems to be lost…But it is also true that a people can 
lose its heritage in a single generation if they neither respect nor value that 
heritage” 
 
It is obvious that, the only way to show respect and value to the heritage in generations is 
to protect it. Protection will assure the sustainable, equitable and fair use of the same for 
the benefit of the society. When asked to comment in the context of defending traditional 
resources rights, the participant stated that;  
 
[in the] “new world of international economic cooperation, trade liberalization, 
and privatization,” institutions like the WTO, corporations, and financial 
institutions are “gaining greater power and assuming the functions of the nation-
state.” These entities are vulnerable to consumer actions, public opinion, and 
investment trends and tools to defend traditional resource rights should be able to 
“reach directly into the conscience and into the pockets of private and non-
governmental sectors.” 
 
Graham Dutfield in his paper66 had also pointed out the need to protect TK in developing 
countries where he was analysing the national systems to protect TK in some selected 
                                                 
64 See, http://www.ubcic.bc.ca/protect.htm visited on September 18th-2006 
65The Chair of the UN Working Group on Indigenous Peoples. Who also is a 1993 recipient of the UN’s 
Human Rights Award. 
66See, Developing and Implementing National Systems for Protecting Traditional Knowledge: A Review of 
Experiences of Selected Developing Countries, available at, http://r().unctad.org/trade_env/docs/dutfieldpdf 
visited on December 18th 2006.  
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countries in Latin America. He argues that, developing countries do not regulate TK in 
their domestic regulations due to two main probable reasons.  
a) Firstly, they probably would like to use it as a negotiating tool in 
multilateral trade issues. 
b) Secondly, they would like more preferential treatment in 
implementation of TRIPS Agreement. 
 
The second reason is based on the facts that, they will be given more time to enact the 
relevant regulations and probably financial and technical support in doing the same. 
However it is the considered view of the researcher that, such reasons are jeopardising 
the rights of these countries in benefiting out of biodiversity and the associated TK, 
which is being taken by the western corporations. 
 
The main concern of protection may also be based on the cultural decay due to the 
increasingly globalization. This had a negative effects on the TK associated with the 
cultures which are dying due to a great influence from other cultures as the effects of the 
world being a village. It is said that, 
 
“cultures are dying out faster than the people associated with them. It has been 
estimated that, half of the worlds’ language-the storehouses of people’s 
intellectual heritage and the framework for their unique understanding of life will 
disappear within a century…67”  
 
It is also noted that, among other things that accelerates the dying of culture and hence 
shows an emergent need to protect the existing TK are; genocide, uncontrolled frontier 
aggression, military intimidation, extension of government control, unjust land policies, 
cultural modification policies, and inappropriate conservation management68.  
 
                                                 
67 See, Inter-Commission Task Force on Indigenous Peoples (1997), as cited by Graham Dutfield (2000) 
Developing and Implementing National Systems For Protecting Traditional Knowledge: A Review of 
Experiences of Selected Developing Countries, pg 5 
68 Ibid 
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All the factors above affects the biodiversity, hence has a negative implication on TK as 
well. African countries are also subjected under the same threats to TK, thus they need to 
take measures to protect their TK for the betterment of its holders. 
 
 
In one of the conference69 one of the participants stressed the need of regulations to 
protect the traditional knowledge when he was presenting on the protection of Traditional 
knowledge and folklore he stated as follows; 
  
“protection of traditional knowledge has become a mainstream issue, and is 
necessary as no satisfactory system of protection exists at present. One threat to 
traditional knowledge is its unauthorized commercial use, without any sharing of 
the ensuing benefits with traditional custodians and communities…” 
 
Protection of TK is against piracy in African societies is of capital importance due to the 
nature of the biodiversity that is always associated with the knowledge itself. Although 
African countries have boundaries, the nature of the biodiversity is always not 
determined by the existing country’s’ boundaries.  
 
However, one had to know what it mean by protecting TK. Is it that the TK should be 
protected against piracy (in the sense that whenever used the holders get the benefits 
directly accruing from the use) or it should be protected in the sense that it should not be 
commercialized at all? Still there is a conflict of the nature of protection of TK.  
 
On one hand, some indigenous people and traditional communities want a positive 
protection that is; they want to benefit from the commercialization of TK. On the other 
                                                 
69 The Conference on the Commission on Intellectual Property Rights: How Intellectual Property Rights 
could Work better for Developing countries and Poor People, held in Royal Society in London in 2002., 
See also, http://www.iisd.ca/linkages/sd/SDIPR/ Visited on October 2006 
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hand some members of these group and communities are concerned with the cultural, 
social and psychological harm caused by the authorized use of TK70.   
 
It is the viewpoint of this research that, it is through protection of TK against piracy 
where by local societies can, either use it for commercial realization of benefits or decide 
to use it for their social and psychological satisfaction in exclusion of others 71. 
 
It is from the above view where one sees a need to raise awareness of the most of the 
developing countries on the need to have the special international and domestic 
regulations governing the access and use of the genetic resources and associated TK for 
their own benefit. 
 
2.1 RELATIONSHIP BETWEEN TK AND GENETIC RESOURCES: 
Before addressing the issue of bio-piracy, it’s worthwhile to know the relationship 
existing between the TK and the biological or genetic resources. On face of it, TK is a 
knowledge just like any other knowledge acquired in formal ways, thus it qualify to be a 
subject of protection under the IP regulations just like any other knowledge. 
 
 However, it may form a kind of exception with other form of knowledge in the sense 
that, it is generally not owned individually but rather the community in which it develops. 
TK develops and reshapes itself perpetually as the society adopts itself into the changing 
environment, hence any attempt to protect it under the current IP regulations, which have 
a specific period of protection, might affect this knowledge. 
 
The relation existing between TK and the genetic resources has its basis on the fact that 
man has to use his knowledge to benefit out of the environment he is surrounded with for 
his food, medicinal plants and animals or even microorganisms. Hanns Ullrich in his 
                                                 
70 See, J.Michael, Finger &P. Schuler (2004) POOR PEOPLE’S KNWOLEDGE: Promoting Intellectual 
Property In Developing Countries, World Bank and Oxford University Press, Washington, pp 12 
71 Professor Ajeet Mathur, in his article titled, WHO OWNS TRADITIONAL KNOWLEDGE? Argues 
that, communities and countries, rich in bio-diversity and knowledge of traditional medicine, may gain if 
they are able to share in trade and investment that arise from the global development of the healthcare 
industry. 
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paper72 pointed out that, biodiversity related traditional knowledge may have a value of 
its own, and being knowledge promise of its protection may be sought under the rules of 
intellectual property or by analogy to these rules. He also pointed out that, in general, the 
biodiversity related knowledge derives its value from genetic resources to which it 
applies. 
 
TK is the intangible part of the genetic resources. The two are inseparable in the sense 
that the value accorded to the genetic resources found its basis in the knowledge that the 
genetic resources worthy it. It is argued that, traditional knowledge is generally 
associated with biological resources and is invariably an intangible component of such a 
biological resource.  
 
TK has the potential of being translated into commercial benefits by providing clues for 
development of useful practices and processes for the benefits of mankind. The valuable 
leads or clues provided by TK save time, money and investment of modern biotech and 
other industries into any research and product development73. 
 
So much as the relation between genetic resources and TK has been established to be 
inseparable. It is at this point one can see the genuineness of the complaint of 
local/traditional societies about the issue of bio-piracy. Its effects are depriving both the 
material and knowledge from local societies, while benefiting the corporations in 
developed countries. However, it is worth to know what bio-piracy means at this juncture 
before the discussion went further 
 
 
 
 
                                                 
72 Traditional Knowledge Biodiversity, Benefit-Sharing and Patent System: Romantics v. Economics 
(2005) European University Institute, Italy pp 6-7 
73 See Elizabeth Varkey, Traditional Knowledge –The Changing Scenario in India, available at, 
http://www.law.edu.ac.uk/ahrb/publications/outline/varkey.htm, visited on October 9th-2006 
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2.2 MEANING OF BIO-PIRACY AND ITS JUSTIFICATION IN 
AFRICAN SOCIETIES: 
 
The word bio-piracy is a blend of two words, which are bio and piracy. The first term, 
bio means concerning living things74, while the second one, piracy mean illegal copying 
and sale of books, tapes, videos etc75. 
 
 However, the list in the second meaning is not exhaustive. It suggests one thing that is, 
the illegal copying and selling of intangible assets. This is the knowledge associated in 
the books and even the tapes and videos and many more. Bio-piracy has been defined in a 
number of ways although ultimately it conveys the same meaning having the same 
elements in these definitions. Some of the elements can be seen in the following 
definitions; 
 
That, bio-piracy refers to the appropriation, generally by means of patents, of indigenous 
biomedical knowledge by foreign entities (including corporations, Universities and 
governments) without compensatory payment76.  
 
Vandana Shiva defines bio-piracy to mean, the use of intellectual property systems to 
legalize the exclusive ownership and control over biological resources and biological 
products and processes that have been used over centuries in non-industrialized 
cultures.77  
 
 It is also referred to as the acquisition of biodiversity, i.e., biological material (plants, 
animals, microorganism, and their parts), or of TK related to that biodiversity, without 
                                                 
74 See Longman Dictionary of Contemporary English: The complete Guide to Written and Spoken English 
New Edition. P112 
75 Ibid pg 1069 
76 See, Meaning of Biopiracy available at, http://en.wikipedia.org/wiki/Biopiracy accessed on September 
5th 2006 
77 Shiva Vandana, (2001) Protect or Plunder: Understanding Intellectual Property Rights, University Press 
Ltd. Bangladesh pg 49 
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the prior informed consent of those whose biodiversity or traditional knowledge has been 
taken78. 
From the definitions above it’s obviously seen that, the term biodiversity may be said to 
have three elements, which are;  
♦ The act of Appropriation (mostly by means of patents) 
♦ ion (mostly has to do with the medicinal genetic 
♦  made to these societies, (owners and custodians of 
the said genetic materials and TK). 
t ill become a best-selling 
imming drug has patented the active ingredient in Hoodia80.  
he use of their TK, and it did not 
ompensate them in any way for the use of their TK81. 
                                                
 Subject matter of appropriat
resources and associated TK79) 
 That there is no any compensation
 
Examples that justify bio-piracy in African local societies are as follows;  
The first can be seen from the cactus plant called Hoodia in Southern parts of Africa a 
tradition being practiced by the Bushmen (San people). Hoodia is a succulent plant that 
grows throughout the semi-arid areas of Southern Africa. The San have traditionally used 
Hoodia stems to stave off hunger and thirst when on long journeys, as it acts as an 
appetite suppressant. Now, a British company who say i  w
sl
 
The idea that the plant can be used to develop a best-selling slimming drug is founded on 
the traditional knowledge and the long time experience held by the Bushmen. The British 
company, which has patented the drug arising out of the use of hoodia did not, first of all 
obtain the prior informed consent of the Bushmen on t
c
 
78 See, Chee Yoke Heong, New report points to widespread bio-piracy in Africa, available at, 
http://biosafety.info.net/file dir/166.doc, visited on August 5th 2006 
79 However this definition may be very narrow in the sense that it consider biomedical resources only and 
ignore other, but it is worth while to note here that the subject matter of appropriation under bio-piracy may 
include non medical genetic resources such as the Basmati rice in India 
80 See, Stolen Knowledge: Article about the Hoodia Kaktus, available at, http://www.evb.ch/en/p5html 
visited on 17th-Decmber 2006, see also, Antony Burnett ‘In Africa the Hoodia Cactus keeps men alive. 
Now its secrets is stolen to make us thin’ The Observer, Sunday June 2001 
81 However, it should be known that, the Bushmen community challenged the patent and they managed to 
get a share of the royalties arising out of the sale of the said drugs. (Although it is always being cited as an 
example of unfair benefit sharing as will be seen later) 
30 
  Another good example of Bio piracy is the use of Maytenus buchananii from Shimba 
Hills in Kenya by National Cancer Institute (NCI) of US, used by Digo to cure cancerous 
onditions82
nt neither is there any policy governing the issues of 
ssociated traditional knowledge.  
rmaceutical is holding patent although there is no any evidence of benefit 
aring.  
it sharing between the holders of the patent and the 
cieties where the plants originated. 
t to the applicant in 
norance if the fact that what actually is being patented is not novel.  
rules and regulations that govern the IP at international level. The regulations provide the 
                                                
c
 
Other examples of possible misappropriation in African local societies include a recent 
report issued by Jay McGown83 include the treatment for diabetes, from Libya and Egypt, 
the patent is being held by the Phytopharm Plc, Co. in UK, but there is no evidence of 
benefit sharing related to this pate
a
 
More over the antifungal from a Giraffes’ dung originating from Namibia, Merck & Co. a 
giant pha
sh
 
From Ethiopia there are about four medicinal plants that have also been patented in US, 
although there is no evidence of benef
so
 
It can be noted that, most of the given examples above did not talk much or clearly about 
the TK as it is on the case of hoodia and Maytenus buchananii. The main reason being, 
the African local societies who are the owners and custodian of the same might have not 
got this information. Therefore, the US patent office had granted paten
ig
 
It is questionable why bio-piracy is taking place in these local societies by the 
corporations from the developed countries. This is so despite the fact that, we have the 
 
82 See, John Mugabe (1999) Intellectual Property Protection and Traditional Knowledge: An Exploration in 
International Policy Discourse, Nairobi, Kenya pg 6. 
83 Jay McGown, (2006) Out of Africa Mysteries of Access and Benefit Sharing, Edmonds Institute in 
Collaboration with African Center Biosafety. 
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minimum requirements to be achieved for the any patent applicant before patent is 
granted to him. In addressing this doubts, Vandana Shiva is of the view that,  
 
“bio-piracy and intellectual piracy in which western commercial interests claim 
products and innovations derived from and currently used by indigenous 
knowledge traditions as their intellectual property protected through intellectual 
property rights  like patents has emerged as a results of the devaluation and hence 
the invisibility of indigenous system of  knowledge  and the lack of protection for 
these system…western style IPR systems are biased towards western knowledge 
systems which reduce biodiversity to its chemical or genetic structures, the 
indigenous systems get no protection, but piracy of these system is protected.”84
 
The continued appropriation of genetic resources and associated TK shows that still the 
western countries are exploiting African society to date. It is obvious that the western 
societies still undermine our continent through their jurisprudence in the multilateral 
trade system where African states are members as well. Professor J.A Ekpere85 is of the 
view that, African societies need to adopt uniform rules in defeating the developed 
countries from exploiting them.  
 
“The further development of this legislation86 at the national level provides the 
challenging opportunity to reflect and recognize Africa’s cultural heritage in the 
laws of the modern national state. It provides a chance for Africa to throw off the 
colonial yoke of western jurisprudence (law making) and develop one that most 
fully reflects its wealth of cultural perspectives and inherently respectful 
                                                 
84 See Vandana Shiva, Protecting Our Biological and Intellectual Heritage, in Peter Darhos (1999) The 
International Library of Essays in Law &Legal Theory: Intellectual Property, Dartmouth Publishing Co. 
Ltd, pg 149. 
85 The Project Coordinator, the Organization of African Unity; Scientific, Technical and Research 
Commission. Nigeria. 
86 The OAU Model Law, The protection of the Rights of Local Communities, Farmers and Breeders, and 
for the Regulation of Access to Biological resources. 
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relationship with the diverse biological world with which its cultures have co-
evolved”87
 
 
Conclusion 
It is worthwhile to conclude that, African local societies need to benefit out of their TK 
once used. The main way to realize this goal is through raising awareness in African 
communities on the need to protect their TK. Protection of TK should be firstly, in their 
domestic regulations and secondly, holding their efforts in trying to strike the balance 
between TK and the western IPR regime at the international level.  
 
This will help them in achieving their goal of protecting the TK and realizing sustainable 
use, equal and fair benefit sharing between the user and the holder of TK.  This is 
because; there are complex issues that have negative effects to the African local societies 
on benefit sharing agreements. These issues will be resolved if there will be domestic 
regulations protecting TK and guiding the benefit sharing to these societies. The next 
immediate chapter will address this complexity in detail. 
 
 
 
 
 
 
 
 
 
 
 
                                                 
87 See, J.A Ekpere, The OAU Model Law, The protection of the Rights of Local Communities; Farmers and 
Breeders, and for the Regulation of Access to Biological resources: Explanatory Booklet, OAU, Scientific, 
Technical and Research Commission. Lagos. 
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CHAPTER THREE 
 
3.0  THE CURRENT PROTECTION OF TRADITIONAL KNOWLEDGE AT 
INTERNATIONAL LEVEL 
The issue to be addressed in this chapter is whether the current international intellectual 
property rights regulation (IPRsR) and policies provide protection of TK associated with 
resources used in medications?  
 
The most common branch of IPRs that will be discussed under this chapter will be the 
Patent system. This is the most notoriously used by the corporations in developed 
countries in plundering the genetic resources and TK from the local societies in 
developing countries. 
 
 
To begin with the Conventions that deals with TK and IPRs, CBD Convention, is the 
only convention which directly tries to protect TK88 among its member states at 
International level. It establishes some requirements such as; 
i) Prior Informed Consent of the holders of TK;  
ii) equal and fair benefit sharing arising from the utilization of such knowledge, 
innovations and practices89. 
 
 TRIPS Agreement on the other hand did not in anyhow make reference to the TK in its 
provisions. Despite the fact that it was signed after the CBD convention90 where one 
would have expected to see the issue of TK being addressed clearly in the latter 
convention as it was dealing with trade issues. 
 
                                                 
88 Despite the fact that it does not define TK but rather referring to the knowledge, innovations and 
practices of indigenous and local communities, embodying traditional lifestyles relevant for the 
conservation and sustainable use of biological diversity, which should be promoted for wider application. 
89 See Article 8 (j) of the CBD Text. 
90 CBD Convention was signed in 1992 in Rio De Janeiro, while TRIPS Agreement came into force in 
1995 as a result of Uruguay Round  
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 However, the provisions that provide for requirements to be fulfilled by patent applicants 
seem to have adverse effects on the issue of TK. The CBD Convention as seen above 
would have been of help but its worth to note here that the Convention is not part of 
WTO Agreements hence it binds only the member states. 
 
More over, despite the fact that CBD convention has provided for the requirements in 
accessing and using the TK, yet it has its own weakness that makes it not suitable in 
guaranteeing TK protection especially in individual countries. This is due to the fact that, 
the convention gave the state the sovereignty to deal with the genetic resources in 
whatever manner in accordance to the established laws. Here the law is silence on the 
link that exist between the genetic resources and the TK, and the fact that, this TK need 
not always be in public domain, it may be individually owned.  
 
 To cement on the above it is argued that, the CBD convention has the qualifier that says 
‘subject to national legislation.’ What if there is no existing national legislation, which 
recognizes indigenous people’s rights? Most countries, which have indigenous peoples, 
do not have such legislation91. 
 
The arguments raised by Sem, seems to be valid since a number of African countries 
although they fight against bio-piracy at an international level by insisting the 
amendments of TRIPS Agreement have no rules/regulation in place in their domestic 
laws to curb this problem at all92.  
                                                 
91 See Sem T. Shikongo (2005) Report on the Threats to the Practice and Transmission of Traditional 
Knowledge Regional Report: Africa pg 16 
92 See the statement made by the Zimbabwe Legal and Parliamentary Affairs principal law officer Jameson 
Mupariwa, where he said that, Zimbabwe had no legal framework to protect traditional knowledge from 
piracy, and had identified this as a weakness in terms of protecting intellectual property. Mupariwa added 
that the absence of a law on IPR was prejudicing holders of traditional knowledge of the benefits they 
should be accruing from their knowledge. He made this statement in the African Regional Intellectual 
Property Organization (ARIPO) workshop on traditional knowledge in Africa, (Zimbabwe develops policy 
to protect Traditional Knowledge) available at, 
http://english.peopledaily.com.cn/200612/15/eng20061215_332730.html# visited on 8th/ February 2007,  
See also, Dr.Patricia Kameri-Mbote, Dr Philippe Cullet, Biological Diversity Management in Africa: 
Policy Perspective, available at http://www.ielrc.org/content/w9902:pdf  Where they argue that, ‘Individual 
African countries are parties to a number  of International Agreements concerning Management  of 
Biological resources. There has also been a regional initiative. The challenge for these countries is to move 
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 Moreover, wherever efforts to establish the same are being undertaken years may pass 
without the same being enacted or even being enforced if at all it will be enacted.  
 
Another international instrument dealing with patent is the Patent law treaty93. The 
Treaty intends among other things to harmonies formalities that patent offices take in 
order to register patent. It may be argued that, this was a good ground for the developing 
countries to raise the issue of amendments of the TRIPS Agreement in their favor. 
However it is worth to note that, despite the fact that they raised such a point the reaction 
of the developed countries was a great obstruction to them.  
 
The worse thing is that, developing countries proposal on the need to have provision for 
disclosure of origin of genetic materials, and proof of informed consent in accessing these 
genetic materials was dismissed. The developed countries argued that, the CBD 
provisions should not be construed as criteria for patentability and would be an 
administrative burden.  
 
During the Patent Law Treaty negotiations, the industrialized countries rejected such 
proposals, arguing that they pertain to the substance of patent law, not procedure.94 It can 
also be argued that, the Treaty is being discussed under WIPO, which is a UN agency, 
and not WTO as it is for TRIPS Agreement. So much so even if it had incorporated the 
proposal of the developing countries, yet it does not form part of the mandatory 
agreements of WTO, as a result enforcement of the same will not be effective as it is 
under WTO. 
 
 
 
                                                                                                                                                 
from the realm of international and regional to the national sphere through effective and concrete legal 
institutional frameworks…’ 
93 This Convention was put in place by WIPO in 2000, although not yet in force up to now 
94 See, ICTSD, A Debate outcome for Trade and Sustainable Development, Johannesburg 2002, available 
at, http://www.ictsd.org   
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3.1 PATENT REQUIREMENT UNDER TRIPS AGREEMENT 
 
For an applicant to be granted patent in any office local or international one, the applicant 
must have to fulfill some requirements. These requirements are; first, the patentable 
subject matter must involve inventive steps, second it should be of industrial applications, 
and third, it should not be obvious in the sense that it’s new or otherwise it should be 
novel95. 
 
However the same provision provides for the exceptions on the other subject matters, 
which cannot be patentable under the same Agreement, where it states as follows; 
 
 “Members may exclude from patentability, plants and animals other than 
microorganisms, and essentially biological process for the production of plants or 
animals other than non –biological and microbiological process. However 
members shall provide for the protection of plant varieties either by patents or by 
an effective sui generis system or any combination thereof.”96
 
From the above paragraph it is therefore clear that, patent shall be available for any 
inventions, whether products or process, in all fields of technology, provided that, they 
are new, involve an inventive step and are capable of industrial application. To cement on 
this, in Diamonds’ case97 the US Supreme court held that,  
 
…process may be patentable, irrespective of the particular form of 
instrumentalities used can not be disputed… A process is a mode of treatment of 
certain materials to produce a given result. It is an act, or a series of acts 
performed upon the subjects matter to be transformed and reduced to a different 
state or thing. If new and useful, it is just as patentable as it is a piece of 
machinery. In the language of patent law it is an art. The machinery pointed out as 
                                                 
95 See the footnote No. 5 of Article 27 (1) of TRIPS Agreement for more elaboration of this 
96 See Article 27 (3) (b) 
97 See, Diamond v Dierh 450 US 175 (1981) 
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suitable to perform the process may or may not be new or patentable; whilst the 
process itself may be altogether new, and produce an entirely new results..” 
 
 The issue to be addressed at this juncture is that, when the TRIPS Agreement refers to 
newness, to who should it be new? This is because what might be obvious in one 
jurisdiction may be regarded as new in another jurisdiction. This kind of controversy  
may allow a product or process to be patented regardless the fact that it was known and 
applied in other countries for the same purposes as what purports to be new in another 
country.  
 
In analyzing the question above it seem clearly that, the patent applicant should satisfy to 
the patent granting authority that his innovation is really new. However, the fact that, the 
current patent system does not recognize TK it is obvious that, once the applicant has 
proved that the innovation is new in the eyes of the granting authority then patent will be 
granted. To comment on the fact that the Patent granting authority are not aware of the 
existing TK when granting a patent, Manuel Ruiz 98 had the following to say,  
 
“Had this traditional knowledge been known to patent authorities – examiners in 
particular at the time of review of patent applications, it may have been 
considered as prior art and, subsequently, may have defeated the claims that the 
invention was new and involved an inventive step. This would have assisted in the 
prevention of “bio-piracy”.  
 
The author seems to suggest one point that, had the TK been considered as prior art, then 
the problem of Bio-piracy would have been finished. On one hand one can join hand his 
ideas, but on the other hand it is challengeable in the sense that, TK may be regarded as 
prior art but still it may guarantee piracy of genetic resources and associated TK from 
developing societies. 
 
                                                 
98 The International Debate on Traditional Knowledge as Prior Art in Patent System: Issues and Options for 
Developing countries (2002) Center for International Environmental Law pg 5-6 
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For example, US laws regard TK as prior art subject to conditionality. Such conditions 
are; that TK must have been registered in US, and that it should have been reduced in a 
form of writing by being publicized in journals in the country of origin.  
 
 These conditionality at first they indicate that US patent laws does not recognize foreign 
TK at all.99 So much so, the conditionality at first negates the generality of the statement 
that, if TK would have been considered as Prior Art, it would have stopped bio-piracy.  
 
Secondly, it shows a kind of discrimination between the foreign and the domestic TK in 
US. This is due to the fact that, if knowledge is new for the US it is novel even if it forms 
part of ancient tradition of other cultures in other countries. This controversy suggests 
that the problem of bio-piracy will be eradicated only where there are uniformity between 
the domestic and international regulations in protecting genetic resources and TK. 
 
3.2 Meaning of Prior Art: 
The term Prior Art by it self refers to the complete body of knowledge, which is available 
to the public before a patent application is filed.  TK is an example of prior art that 
always exists before the patent granted basing on TK has been issued by the patent 
authority.  
 
 The Fact that the knowledge had been in use by the African societies for quite long in 
treating various illnesses using the same tree or genetic resources, should be taken into 
account by the Patent granting authority. This will accord recognition to TK and reduce 
the rate of bio-piracy in African local societies. 
 
 However, this has been to the negative and instead the existing IPR regulations instead 
of fighting against bio-piracy it actually perpetrate the same. To justify this, there are no 
any international regulations that seem to reconcile the existing conflict between the law 
                                                 
99 See, Section, 102 of US Patent Act, which allows prior foreign knowledge, use and innovation to be 
excluded when the question of Prior Art is considered in relation to US Patent application, See also, US 
Patent System Legalize Theft and Bio-piracy available at, 
http://www.organicconsumers.org/Patent/uspatsys.cfm visited on October 17th 2006 
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and the practice in granting patent regardless of the fact that there is TK that existed 
before the application of the same. 
 
The law should by no how allow any misappropriation of TK by adhering to the patent 
system that does not recognize the newness of the invention by the patent applicant, to 
comment on this Vandana Shiva has the following to say; 
 
“If a patent system which is supposed to reward inventiveness and creativity 
systematically rewards piracy, if a patent system fail to honestly to apply criteria 
of novelty and non obviousness in the granting of patents related to indigenous 
knowledge then the system is flawed, and it needs to be changed. It can not be the 
basis of granting patents or establishing exclusive marketing rights…”100
 
The author goes on saying that, the problem of bio-piracy is a result of the western IPR 
system not the (domestic) Indian law. This means that, the Current IPR system need to 
change but not the domestic laws of India (developing countries). 
 
 With, this assertion, the researcher; would like to differ with the author in one way. That 
is, had Indian (domestic) laws and regulations on access and use of genetic resources and 
associated TK was intact and in favor of the local societies, the western Multinational 
Corporations would not have been able to access the said genetic resources. Thus it 
would have reduced if not stopped the acts of appropriation in India. 
 
 This shows the truth that, despite the fact that, the international IPRs regulations do not 
provide an answer to bio-piracy yet the domestic regulation will help in curbing this 
problem.  Thus the African local societies will only benefit out of TK when they will 
manage to protect genetic resources and TK domestically and internationally as well.  
 
 
                                                 
100 See, US Patent System Legalizes Theft and Biopiracy, available at, 
http://www.organicconsumers.org/Patent/uspatsys.cfm visited on 17th October 2006  
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3.3 THE COMPLIXITIES OF EQUAL AND FAIR BENEFIT SHARING AS 
EXPIRIENCED IN AFRICAN LOCAL SOCIETIES: 
 
The Convention on Biological Diversity is insisting on the access, equal and fair benefit 
sharing between the provider of the genetic resources and the users.101 It further requires 
each signatory to make sure that the local societies benefit once others are utilizing their 
genetic resources and TK. 
 
“Subject to its national legislation, respect, preserve and maintain knowledge, 
innovations and practices of indigenous and local communities embodying 
traditional lifestyles relevant for the conservation and sustainable use of its 
biological diversity and promote their wider application with the approval and 
involvement of the holders of such knowledge, innovations and practices and 
encourage the equitable sharing of the benefits arising from the utilization of such 
knowledge, innovations and practices”102  
 
 However, as it is seen above, its provisions on benefit sharing are not so detailed so as to 
provide answers to complex issues that may arise in the area of benefit sharing. 
 
 One may argue that, it contemplated one provider and one user of the genetic resources, 
or rather an organized group of providers and users. Moreover it even point that it will 
not deal with the agreements that were entered into between states prior it being in 
force.103  
 
The insistence to have effective and detailed domestic laws and legal institutional 
frameworks to deal with the problem of bio-piracy as afore said should be highly 
considered now. This is because the western multinational corporations use the gap in 
                                                 
101 See Article 2 of the CBD Convention  
102 See Article 8 (j) of the Convention on Biological Diversity concluded at Rio de Jeneiro in 1992 
103 It is also questionable as to whether it will deal with the misappropriation acts that took place before it 
comes into force. It is at this point where we see the need to have policy/ regulations that will also provide 
the basis for the challenge of the already pirated TK and the genetic resources in these local societies. 
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their favor if a country has no regulations at all or where are less detailed or even where 
they lack enforcement.104
 
Sometimes where there is lack of seriousness on the side of the enforcers or even the 
negotiators of the bio-prospecting agreement, these corporations are even ready to 
jeopardize the so-called equal and fair benefit sharing. A good example is drawn from 
Zimbabwe and the San people in the Southern part of Africa. 
 
In Zimbabwe’s case, the agreement between the Zimbabwe University (as a beneficiary) 
and Luasanne University was clear to the effect of showing how the parties will benefit 
out of the contract by filling a joint patent application.  
 
 However, the later proceeded applying for patent and eventually was granted at the 
detriment of the beneficiary. In reacting against this the Vice Chancellor of Zimbabwe 
University had the following to say; 
 
“While the research agreement is by no means a perfect document, the University 
of Lausanne obviously made no effort to respect the content and spirit of the 
agreement. The conduct of Lausanne University clearly demonstrates that the 
illegal appropriation of biological resources from developing countries is still 
common practice by northern Universities (research institutions) and 
corporation”105  
 
The case above is a representative of a number of anomalies that are likely to occur in 
African local societies, if there are no strict domestic regulations. These anomalies 
include the fact that, in this case only the Zimbabwe University was part of the benefit 
sharing agreement. The government and the other stakeholders like the local society were 
                                                 
104 This may happen because of lack of Institutional Legal Framework to enforce the said regulations 
105 See, The Government and University of Zimbabwe determined ton stop Bio-piracy by Swiss University. 
Available at, http://www.evb.ch/ev/p25000453.html visited on 17th December 2006 
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not involved. It is also argued that the medicinal plant was given to Lausanne University 
at a less than fair value.106
 
In recent case in Africa representing the unfair benefit sharing as mostly cited case is that 
of Hoodia. In this case the traditional Bushmen society received very low percentage of 
the royalty received by the research institution in South Africa. In analyzing this benefit 
sharing agreement between the San and the users of their TK, the legal adviser of the San 
Organization had the following to comment,  
 
“Despite positive reactions by many stakeholders on this agreement, it has to been 
recognized that the provisions are highly restrictive with respect to the San as the 
original rights holders and highly protective with respect to CSIR as the current 
patent holder. For example, any intellectual property arising from traditional 
indigenous knowledge of use of Hoodia and related to CSIR belongs to CSIR, the 
San will not contest CSIR patent, the San will not enter into competing agreement 
with third parties, the San are not involved in the multi-million dollar licensing 
negotiations of Phytopharm, and they finally will not benefit from future product 
sales.”107
 
The two cases raised an issue in common when one refers to benefit sharing agreements. 
The issue is, to whom is this benefit actually intended to be shared? This issue is worth 
raised at this point because with the trend of two cases above it is clear that, the holders 
of the TK seem to be the neglected or rather oppressed by being the fourth in 
consideration of benefit.  
 
The first are the western multinational corporation, the second are the research 
institutions (mostly Universities or research centers) and lastly we find local societies 
who are always being marginalized or exploited by these two big parties. 
 
                                                 
106 Ibid 
107 See, The Hoodia case: the San experiences with benefit-sharing agreements 
Side event at COP-8, 29 March 2006 
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 In Hoodias’ case for example, the South African research institute researched on the 
hoodia. It ultimately transferred its rights to a British pharmaceutical corporation. In this 
transaction, the research institute had a better share of benefit in comparison to the 
original holders of the knowledge about hoodia.108
  
However, when one considers the main concern of CBD convention, he also had to 
consider the state as the owner of all resources109. Thus, the issue of equal and fair 
benefit sharing is still been complicated at this juncture. It needs a clear explanation 
within the domestic regulations rather than at international level. 
 
 It is the strong standpoint of this thesis that, exploitation of the local communities in bio-
prospecting agreements with the users of TK should be avoided. This can be achieved by 
setting a fixed minimum benefit sharing that the users should give to the local societies in 
any event their TK is used. Without this, the issue of equal and fair benefit sharing will 
still benefit the research institutions while leaving the holders of this valued knowledge 
with nothing.  
 
The above idea is founded on the existing relations between the holders of TK and 
genetic resources in comparison with the users. The relation has always been between the 
two contracting parties, one (which is the user) always having the high bargaining power 
than the other (holders of TK).110  
 
In his comments about the imbalance between the user and the holder of TK, (Mr. 
Murasoli Maran) the then Indian Minister of Commerce and Industry had the following 
to say, 
“IPR laws must benefit all the holders of such IPRs equally - whether they are 
huge multinationals spending billions of dollars on research or traditional local 
                                                 
108 The same reason was also discussed in Zimbabwe’s case where it was said that, the University was the 
only beneficiary hence it marginalized other stakeholders like the government and the traditional hillers. 
109 See the preamble of the CBD Convention that grants states sovereignty over their own biological 
resources 
110 See UK Governmental Commission on Intellectual Property Rights pg 85 
44 
communities where knowledge has simply been passed on from generation to 
generation”111
 
To achieve the said above balance in benefits, there need be effective laws and 
regulations on benefit sharing.  These regulations need to be directed in protecting the 
interest of the local communities involved in bio-prospecting agreements. 
 
The third example is of a plant112 pirated from Tanzania where one can see clearly the 
complex issue of who are to be the beneficiaries on the same. It is seen to be a really long 
chain of stakeholders to the extent of fail to consider the issue of equity but rather 
fairness.  
 
In Tanzanian case of bio-piracy as indicated113 there is no any agreement on issues of 
equal and fair benefit sharing. Despite the fact that the company that holds patent on the 
plant (Syngenta) benefit out of it commercially in gardening and other associated uses114.  
 
However, the way the plant finds its way to the hands of the Syngenta is a long chain. It 
is questionable whether the issue of equal and fair benefit sharing should involve the 
whole chain. The summary of it runs as follows, 
 
“The patent discloses the source of the genetic materials that Syngenta used to be 
from the Royal Botanical Gardens in Edinburgh. The latter stated that they had 
received their seeds in 1982 from the Royal Botanical Gardens at Kew where they 
had been deposited “in 1976 by Christopher Grey-Wilson, a former president of 
the Alpine Garden Society.” Syngenta stated that it obtained the seeds it used in 
                                                 
111 See An International Seminar on Systems of Protection of Traditional Knowledge, New Delhi; by India 
and UNCTAD during 3-5 April, 2002. 
112 The plant has no direct link with medical use, (although there are arguments that it may be used for 
treatment of cancer, I found no where concrete evidence of the same) I find it a good example to be used in 
trying to explain how complex the issues of benefit sharing may be, which will have negative implication 
to the local societies who are custodians or even those who have conserved the environment in which the 
useful plant was found. 
113 See Antony Barnnet, The new piracy: How West steals African Plants, The Observer; August 27th 2006 
available at, http://www.gurdian.co.uk/science/story/html visited on 4th/ 12 2006 
114 It is argued that, For those not from this part of the world, gardening has been one of the fastest growing 
hobbies in North America in recent years so the quest for the perfect trailing plant for hanging basket 
displays - while not exactly a cure for cancer - is potentially a great money-maker. 
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1990 and that when the company received the seeds, no one knew exactly which 
country they came from.115” 
 
Who then should enter the agreement of benefit sharing between the users and the 
provider, should it be only between Syngenta and Tanzanian Government, or should it 
also involve the local societies of the place where the plant was found (Usambara 
Mountain)?  What about other groups who were in one way associated with it, such as the 
Royal Botanical Gardens?116  
 
Having in mind the above complexities existing in the general concept of equal and fair 
benefit sharing in using the genetic resources in developing countries, especially on the 
number and nature of the stakeholders involved.  It is questionable, how far then the 
developing countries are prepared to face these complex issues. 
 
These issues had to be addressed with the aim of protecting the interest of the traditional 
(local) community who are the custodians of the knowledge and the materials. These 
stakeholders use these materials and knowledge in furthering research and new 
discoveries. As shown above, these local societies are always forgotten. In an event they 
are remembered then, they are last group to be considered and always receive very little 
as their benefits despite the fact that, they are the originators of this knowledge. 
 
 
 
 
                                                 
115 See, Antony Barnett, The new piracy: How West steals African Plants, The Observer, August 27th 2006 
available at, http;//www.gurdian.co.uk/science/story/html visited on December 4th 2006 
116 See, ‘The comments on CBD, Intellectual Property and ABS’. ‘… the story illustrates some of the 
complexities of ABS. If Syngenta was to consider entering into a benefit-sharing agreement, who would it 
share the benefits with? The Royal Botanical Gardens in Edinburgh where it got the seeds? The Royal 
Botanical Gardens at Kew where the seeds had come from previously? The Tanzanian government - 
Tanzania being the country where the plant with the trailing characteristic was found? Or a local 
community in Tanzania? In all likelihood, a number of these players would probably need to be involved. 
ABS contract negotiations are rarely between one user and one provider. The multitude of different actors 
can make them costly undertakings - even before the benefit-sharing begins…, available at 
http://karthryn.garforthmitchell.net, visited on November 29th 2006. 
46 
 3.4 THE DEVELOPED AND DEVELOPING COUNTRIES BALANCE OF 
INTEREST ON ACCESS AND USE OF GENETIC RESOURCES AND 
ASSOCIATED TK. 
 
Having seen the pot-holes in the international instruments dealing with the protection of 
TK in African local societies, it is questionable as what should be done for there to be a 
balance between the holders of TK and the users? 
 
In addressing the above issue, it can be said that, the provision of Article 27 of TRIPS 
Agreement had a safety valve to these African societies although its implementation 
seems to be a problem. 
 
 The provision states that it will be reviewed in first five years after the agreement come 
into force. The agreement came into force in 1995, thus it ought to have been reviewed in 
the year 2000 so as to address other issues among which TK is the main. 
The African countries and other developing countries that are being marginalized by the 
current IPR regime as it is biased towards the western approach have shown their interest 
to have the TRIPS agreement amended by presenting their proposals in various meeting 
discussing the same.  
However, the developed countries oppose the African or rather the developing countries 
approach, by providing their own approach in which they think will be wise to amend 
TRIPS agreement to handle the current trend in curbing bio-piracy. This situation forms 
two opposing side on the modality of amendments.  
The TRIPS amendments were mainly focused on how to deal with the commercial use of 
TK and genetic material by those other than the communities or countries where they 
originate. It was mainly directed where TK are the subject of patent applications, it was 
also aimed to ensure that the TRIPS Agreement and the UN Convention on Biological 
Diversity (CBD) support each other. 
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It should be noted here that the Doha round of negotiation had also mandate to discuss 
issues pertaining TK but unfortunately it bears no fruits as it collapsed117. 
 
It is at this juncture one need to see the possibilities of balancing the interests of these 
two groups. This situation roughly can be said to represent the users (the western 
countries) and the providers that represent the developing countries. 
 
The developed countries would like TK to be commercialized while maintaining the 
current position of the TRIPS Agreement that actually does not recognize TK. On the 
other hand the developing countries would like the protection of TK, both against 
commercialization118 and in commercialization, and at the same time pioneering for the 
amendments of the TRIPS Agreement to the extent of recognizing TK. 
 
The developing countries’ proposal119 is to the effect that, the TRIPS Agreement needs to 
be amended to contain the requirement for the disclosure of the origin of genetic 
materials that are used in any discovery of any drug (subject matter of patent). It also 
requires the patent applicant to provide evidence of the contact of benefit sharing in 
between the applicant and the local society in developing country who are the custodians 
of the TK.  
 
All this is aimed at assuring protection of TK and realization of fair and equal benefit 
sharing arising from the use of the biodiversity and TK.120 However this proposal seem 
                                                 
117See, Paragraph 19 of the 2001 Doha Declaration, which says that, the TRIPS Council should also look at 
the relationship between the TRIPS Agreement and the UN Convention on Biological Diversity and at the 
protection of traditional knowledge and folklore 
118 In the sense that, commercialization of TK should not interfere with the religious or moral belief of 
some societies in Africa.  
119 The proposal put forward by group represented by Brazil and India and including Bolivia, Colombia, 
Cuba, Dominican Republic, Ecuador, Peru, Thailand, and supported by the African group and some other 
developing countries, available at www.wto.org  
120 See, the TRIPS: Reviews, article 27.3(B) and related issues background and the current situation, 
available at, www.wto.org visited on 6th/February 2007 
 
 
48 
also to be general in the sense that it does not require the fixed percentage (minimum 
benefit) below which the users will not be allowed to give to the local societies in 
developing countries. It is the considered view of the researcher that the same need to be 
provided for in the domestic regulations so as to assure protection of the local societies 
against the western corporations and other stakeholders, who are involved in the bio-
prospecting agreements. 
 
The developed countries however, are in opposition to the developing countries’ proposal 
as they argue that, they would like the issue of benefit sharing be considered bilaterally 
between the user and the provider of the biological resources121. They justify this by 
arguing that, even if the developing countries’ proposal would have been accepted yet, 
there should be a bilateral agreement between the provider and the user.  
 
However this argument seems to have truth in it but it does not nullify the developing 
countries’ proposal. This is because, there will be different approach in the countries 
hence distorting the uniformity regarding the value of TK, also the issue of enforcement 
will be a problem as it will be a dispute outside WTO realm hence affecting the end result 
of the initiatives taken. 
 
3.5 Conclusion: 
 In summary it can be said that, there is a need to have TK being protected against bio-
piracy done by the western pharmaceutical corporations. It is through protection in both 
domestic and international regulation (having TRIPS agreement amended) where the 
local society will benefit out of their knowledge. 
 
To be more precise, the domestic regulation should provide for a minimum profit sharing 
percentage between the user and the local society.  Moreover, effective legal institutional 
framework dealing with issues of access to genetic materials need to be established. This 
                                                 
121 See, US is of the view that, the Convention on Biological Diversity’s objectives on access to genetic 
resources, and on benefit sharing, could best be achieved through national legislation and contractual 
arrangements based on the legislation, which could include commitments on disclosing of any commercial 
application of genetic resources or traditional knowledge. Available at www.wto.org  
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will help to avoid exploitation of the local society by the other financially giant 
stakeholders who forms part of the benefit sharing in bio-prospecting agreements. In 
doing this the IPR regulations will definitely be striking the balance of interest between 
the users and the providers of TK.   
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CHAPTER FOUR 
 
 
THE DOMESTIC REGULATIONS ON PROTECTION OF TK IN SELECTED 
AFRICAN COUNTRIES 
 
4.1 SOUTH AFRICAN REGULATIONS WHICH GOVERNS TK. 
 
4.1.1 Introduction 
South Africa has a number of well-established regulations, which governs the access, use, 
and patenting of the genetic resources which are always associated with TK. These 
regulations are aimed at assuring sustainable, equal and fair use of the genetic resources 
and associated TK to the nation and any other stakeholders like the local societies. These 
regulations are enacted as a result of recognizing the need to protect the bio-diversity. 
Bio-diversity has to be protected, as many populations are directly dependant on it for 
job, food, and shelter, medicines and spiritual well being122. 
 
4.1.2 Protection through Biodiversity Act 
 
The protection of biodiversity in South Africa by a special enactment of the law that 
regulates the access, use and benefit sharing in the country, has in one way protected the 
rights of the local societies. The provisions of the law and the institutions established by 
the law has a lot of contributions in assuring sustainable, equal, and fair use of the genetic 
resources between the stakeholders. 
 
To begin with the Biodiversity Act123 the Act was initiated by the South African Ministry 
of Environmental affairs and Tourism. The Act establishes some regulations on access 
and use of genetic resources in South African jurisdiction... 
 
                                                 
122 See The South Africa’s National Bio-diversity Strategy and Action Plan 2005. 
123 Republic of South Africa, Biodiversity Act No.  2006 
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“No person may, without a permit issued in terms of Chapter 7- 
(a) engage in bio prospecting involving any indigenous biological resources; or 
(b) export from the Republic any indigenous biological resources for the purpose of bio 
prospecting or any other kind of research.124” 
 
This means that no person shall without previous approval of the National Biodiversity 
Authority obtain any biological resource occurring in South Africa or knowledge 
associated thereto for research or for commercial utilization or for bio-survey and bio- 
utilization. 
 
The Act seems to protect the interest of the holders of TK and the general concern of the 
genetic recourses. The general requirement on access and use of genetic resources seems 
to have been included in this Act. Requirements of prior informed consent of the holders 
of the genetic resources and TK and proof of benefit sharing agreement between the 
stakeholders and the local society. This by itself shows a good approach by the law in 
protecting the rights of the locals. 
 
“If a stakeholder has an interest as set out in subsection (l) (a), an issuing 
authority, may issue a permit only if, 
a) the applicant has disclosed all material information relating to 
the relevant bio prospecting to the stakeholder and on the basis 
of that disclosure has obtained the prior consent of the 
stakeholder for the provision of or access to such resources;  
b) the applicant and the stakeholder have entered into- 
(i) a material transfer agreement that regulates the provision 
of or access to 
(ii) a benefit-sharing agreement that provides for sharing by 
the stakeholder such resources; and in any future benefits 
that may be derived from the relevant bio prospecting; and  
                                                 
124 See Section 81 (1) of the South African Biodiversity Act 2006 
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c)  the Minister has in terms of sections 83(2) and 84(2) approved 
such benefit-sharing and material transfer agreements.” 
 
From the above provision provides a clue that the minister concerned has to approve the 
benefit sharing agreement in any bio prospecting agreements between the local societies 
and other stakeholders125. This might be a good approach if at all the minister may be 
serious in defending the rights of the local societies.  
 
Thus in any event where in the benefit sharing agreement the local societies seems to be 
marginalized the minister may withhold his right to approve the agreement hence no 
permit will be granted. Otherwise, the local societies are still subjected to the giant 
stakeholders who will always marginalize them unless there are clear set rules or 
regulations on minimum benefit sharing to these societies. 
 
4.1.3 Established Institutions 
The Act has established an institution to enforce the Act, this shows the seriousness of the 
initiatives in protecting the biodiversity and TK associated with. The Bio prospecting 
Trust Fund was established to take care of the benefit sharing agreements between the 
stakeholders in these agreements. 
 
“A Bio prospecting ‘Trust Fund is established into which all moneys arising from 
benefit-sharing agreements and material transfer agreements, and due to 
stakeholders, must be paid, and from which all payments to, or for the benefit of, 
stakeholders must he made.”126
 
The institution like this will be helping the local societies in negotiation of the benefit 
sharing agreement where the government will also be a party. However, the Minister may 
exempt the indigenous biological resources from the above provision. In an event the 
                                                 
125 See also section 84 (2) of the South African Biodiversity Act 2006 
126 See Section 85 (1) of the South African Biodiversity Act 2006 
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minister exercise this, the local societies will be left vulnerable in hands of the giant 
stakeholders in bio prospecting agreements. 
 
Generally, the situation above shows that the rate of bio-piracy in South Africa will be 
cut down if not stopped by this law and the established institutions to regulate the access 
and use of genetic resources. 
 
4.1.4 Protection through Patent 
Regarding patent requirement, the law has changed to reflect the need to protect TK and 
thus assuring equal and fair benefit sharing between the stakeholders of genetic resources 
and the associated TK. For example, the current amendment of Patent Regulations in 
South Africa shows that TK and genetic resources are being protected. The provisions in 
the regulation states as follows; 
 
“Where the Form P26 contains a statement that the invention for which protection 
is claimed is based on or derived from an indigenous biological resource, a 
genetic resource, or traditional knowledge or use, the applicant shall, before 
acceptance of the application furnish the registrar with proof of his or her title or 
authority to make use of the indigenous biological resource, the genetic resource, 
or the traditional knowledge or use, by lodging with the registrar one or more of 
the following:  
(a) a copy of the permit issued in terms of Chapter 7 of the National 
Environmental Management: Biodiversity Act, 2004;  
(b) if applicable, proof that prior consent had been obtained as 
contemplated in section 82(2) (a) or 82(3) (a) of the National 
Environmental Management: Biodiversity Act, 2004;  
(c) if applicable, proof of a material transfer agreement as contemplated in 
section 82(2) (b) (i) of the National Environmental Management: 
Biodiversity Act, 2004;  
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(d) if applicable, proof of a benefit-sharing agreement as contemplated in 
section 82(2) (b) of the National Environmental Management: 
Biodiversity Act, 2004;  
(e) if applicable, proof of co-ownership of the invention for which 
protection is claimed;  
(f) any other proof to the satisfaction of the registrar.127” 
 
From the above provision, it will be noticed that the first requirement is indispensable. 
However, requirements numbered (b-f) seems to be in alternative. This means that it will 
depend on the nature of the agreement reached between the holders of TK and the other 
stakeholders. If two or more elements as stated in (a-f) are available, then those 
documents will be necessary in patent application.  
 
In this amendment it is clearly seen that it supports the Biodiversity Act that regulates on 
access and use of the genetic resources and associated TK. The domestic regulations in 
South Africa seem to be interlinked in a good way to assure the protection of 
environment, genetic resources and associated TK. 
 
4.2 TANZANIAN REGULATIONS ON TK 
 
4.2.1 Introduction 
Tanzania is a member country of African Intellectual Property Rights Organizations 
(ARIPO). In this organization there are some agreements on issues of Intellectual 
Property like patent. A good example of the agreement in this organization is, Harare 
Protocol128. This shows that Tanzania apart from being bound in its own local 
                                                 
127 See South African Patents-memorandum on prosecuting a pct national phase application in South 
Africa (revised May 2006 - patent regulations amended) 
http://www.hahn.co.za/patent-information.htm; accessed on 17th, December 2007 
128 The Protocol on patents and industrial designs within the framework of the African regional intellectual property 
organization (ARIPO), (adopted on December 10, 1982, at Harare (Zimbabwe), and amended by the Administrative 
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regulations, it is also bound at International level in accordance with the agreements it 
has entered into with other countries129. Domestically, there are regulations like the 
Patent Act, Forest Act130, the National environment Policy and The Traditional and 
Alternative Medicines Act131 that may also have impact on genetic resources and 
associated TK. 
 
4.2.2 Critical Analysis of the Regulations that Governs TK in Tanzania 
 
4.2.2.1 Institutional Arrangements 
Generally speaking, the Tanzanian bio-diversity protection is not regulated under one 
ministry and a well-established legal institutional framework as compared to South 
Africa132. In the exploration and export of floral resources of potential medicinal value, 
currently is regulated by various ministries and departments such as: 
• The Department of Agriculture with cooperative societies, 
• The Departments of Natural resources and Tourism, and 
• The Departments of Trade and Industries, and Health. 
 
Because of the various stakeholders involved in the conservation and utilization of 
biodiversity, the law does not say anything about specific plant species. For example, 
under the Ministry of Agriculture and Cooperative Societies, the Natural Agricultural 
Products Law of 1969 deals with the control of sales, transport, storage, processing and 
trading of agricultural resources; while the Ministry of Tourism and Natural Resources 
deals with the conservation and management of forests and forest products focusing on 
                                                                                                                                                 
Council of ARIPO on December 11, 1987, April 27, 1994, November 28, 1997, May 26, 1998, November 26, 1999, 
November 30, 2001 and November 21, 2003 and as amended by the Council of Ministers on August 13, 2004) 
129 See, Annexure B, that contain the list of member states of Harare Protocol and date on which state become a party 
to the protocol. 
130 Act No 7 of 2004 
131 Act No. 23 of 2002 
132 This has been seen in the previous part of this chapter dealing with South African regulations on TK. 
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forest reserves. There is no emphasis on establishing a unified policy among different 
ministries (e.g. the Ministry of Trade and Industries and the Ministry of Health), to guide 
the collection and export of medicinal resources. 
 
Regulations governing the exploration, export, and conservation of fauna and marine 
resources are issued by the relevant departments of different ministries. Various 
regulations from different ministries exist but there is no single regulation that spells out 
how to control and regulate the exploration, export, and conservation of medicinal 
resources derived from animal and marine life.133
 
There are other institutions that deal with the regulations of TK and biodiversity in 
Tanzania. These institutions include the local authorities that deals with the issuing of 
permit to any one with a license to conduct research in local reserved forests. Also there 
is the National Research Council which regulates all research based activities in all 
disciplines.134 However, these institutions have their weakness in formulating and 
implementation of the regulations as are discussed here under. 
 
4.2.2.2 National Environmental Policy 
The National environmental policy has one among other objectives, to ensure sustainable 
and equitable use of resources in meeting basic needs in the society. (No connection with 
the quotation below) 
 
‘To ensure sustainability, security and equitable use of resources for meeting the 
basic needs of the present and future generations without degrading the 
environment or risking health or safety’135
                                                 
133 See, Sophia Twarog and Promila Kapoor, (Ed), protecting and promoting systems, national experiences and 
international dimensions, (2004) United Nations, New York and Geneva, pg 18 
134 See  Regulation 22 (6) of the Draft of the Traditional and Alternative Medicines (Regulation of Materia 
Medica) Regulations 2007 
 
135 See, United Republic of Tanzanian, National Environmental Policy, December 1997, pg 4  
57 
 However, the policy is silence on the issue of accesses and use of the genetic resources 
and associated TK available in Tanzania for the benefit of Tanzanians. One could 
imagine that the reference to sustainable use of resources in the policy would encompass 
all these. And in this era of wide spread of bio-piracy the policy ought to have been clear 
and detailed on the issues of access, use and benefit sharing. This would have assured the 
society at grass root of the benefit out of their biodiversity and TK. Unfortunately, there 
is no such a thing. 
 
Additionally, the policy does not address on the need to have established legal institutions 
controlling the rights of the societies that depend on environment for their healthy, and in 
addressing the likely effects of commercialization of the bio-resources.  
 
The policy is categorically explaining about the conservation of the forests that contain 
biological diversity and genetic resources. However, it is silent as to whether these 
resources can be commercialized or not. Furthermore, if they are commercialized the 
policy is not clear on what criteria should the responsible officer deal with for the benefit 
of Tanzania. For examples, issues of negotiating about semi-processing industry in 
Tanzania, or value added genetic resources before they are to be sold abroad, or even 
issues of benefit sharing through royalties.136
 
 
 
 
4.2.2.3the Draft Traditional and Alternative Medicine Regulations 2007 
Regarding medical research on traditional herbs in institutions in Tanzania, it was 
revealed that the researchers always depend on the information from the local societies in 
their medical discoveries.137 This being the case, the institutes always has a close ties 
                                                 
136 See Tanzanian National environmental Policy, 1997, pg 18, although the issue of royalties is well 
covered under the Tanzanian Forest Act, while other issues left aside. 
137 See annexure C for the Questionnaires issued in this research. 
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with the local societies in training them and raising their awareness about the need to 
disclose their knowledge in traditional medicines. 
 
 However, there is a loophole seen in dealing with the genetic resources and the 
associated TK in these research institutions. This loophole is based on the fact that there 
are no special regulations/policy/guidelines in place to regulate the amount of genetic 
resources to other research institutions abroad.138
 
This by it self provides a lacuna for appropriation to take place in our jurisdictions. This 
lacuna is not only under these institutions but generally reflect the weakness in the 
National Research Council, which is the head of such institutions. That is to say, the 
national research council ought to have laid down the rules/guidelines to regulate the 
amount of genetic resources to be exported for further research abroad. 
 
Currently, there are on going initiatives in assuring that the research institutions are 
provided with the regulations or policies to protect the transfer of genetic resources 
TKB.139  In their first draft regulations140, the following loopholes can be pin pointed: 
 
Firstly, the protection of the local societies seems not to be the concern of the regulation. 
This is reflected in the draft regulations where there is no any provision with a fixed 
percentage of what will amount to benefit sharing to the local societies when entering 
into bio-prospecting agreement with the economic giant institutions or western 
corporations. 
 
                                                 
138 This was revealed in the reply of the questionnaires issued on 16th March 2007 to Dr E. J 
Kayombo (Head of Department of Medical Botany, Plant breeding and Agronomy. Institute of 
Traditional Medicine, Muhimbili University Collage; University of Dar es Salaam) 
139 These initiatives are made under Section 55 (1) and (2) of the Traditional and Alternative Medicines Act 
No. 23 of 2002 
140 See the annexure C  
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However, part VI of the draft regulations, which deals with the research, has made some 
reference on the memorandum of understanding in collaborations with the local 
practitioners.  The National Research Council has to be satisfied with the memorandum 
entered into for the interest of the local practitioners and the country. 
 
“The Council shall satisfy itself that the memorandum of understanding 
safeguards the interests of traditional and Alternative Health Practitioners, the 
council and the country.141” 
The above-proposed draft could be said to constitute to the protection of the interest of 
the local societies in any bio-prospecting agreement, although not so straight to the point 
of establishing a fixed percentage as pinpointed in the previous paragraph. 
 
Secondly, the regulations, did not pin point the criteria used in granting a permit for the 
export of the material medical or in any bio-prospecting agreement. This by itself seems 
to be left to the discretion of the permit granting authority. The draft regulations ought to 
have to spell out the criteria’s like; 
a) Mandatory value added processing industries being established in our country 
b) Establishing subsidiary industries in the areas of origin of the traditional herb that 
lead to medical discoveries. 
c) Establishing large estates in cultivation of the herb that was discovered to have 
medicinal value 
d) Encouraging joint-ventures in the pharmaceutical and research experts between 
the local and foreign institutions or corporations. 
e) Establishing research institutions in our jurisdiction and entering into an 
understudy with our local experts.  
f) Filling for joint patent application in an event their research has positive results in 
any drug discoveries. 
If the criteria above will be taken into consideration in all the bio-prospecting 
agreements, the society will get more benefit rather than royalties by themselves.  
                                                 
141 See, Regulation 22 (6) of the Draft of the Traditional and Alternative Medicines (Regulation of Materia 
Medica) Regulations 2007 
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 4.2.2.4 Protection through Forest Act 
Despite the above stated loopholes, part VII of the Forest Act142 prohibit any export of 
any forest produce143 without a permit from the authority. This part of the Act deals with 
trade in forest produce. It is thus seen in one way that the forestry product are protected 
from plunder by the western corporations if at all the law is to be effectively enforced. 
 
“No person shall export or enter for export any timber or other forest produce 
Unless; 
(a) he has a valid export certificate issued by the Director in respect of that 
timber or other forest produce; or 
(b) that timber or other forest produce has by an order made by the 
Minister and published in the Gazette been exempted from the provisions 
of paragraph (a).144” 
 
 
The problem is still with the produce, which are not forestry.  This is because the Act is 
silent on the issue of non-forest produce. It means that, where a traditional healer has 
managed to have his own herbal garden, he is not under the umbrella of the Act. This 
exposes his knowledge about the medicinal value in those herbs and hence vulnerable to 
bio-piracy. This is  taking into account the techniques used by the western pharmaceutical 
                                                 
142Tanzania Forest Act, Act No 7 of 2004 
143See definition section of the act , where the term forest produce is referred here to mean, “anything 
which is produced by or from trees or grows in a forest or is naturally found in a forest and includes 
bamboos, bark, bast, branch wood, canes, charcoal, earth, fibers, firewood, fruits, galls, gums, honey, latex, 
laths, leaves, litter, natural varnish, peat, plants. Poles, reads, resin, roots, rushes, sap, sawdust, seeds, slabs, 
timber, trees, thatch, wattles, wax, wild silk, withies, wood shes, wood oil, and any other living or 
inanimate object declared by notice in the Gazette to be forest produce for purposes of this Act;” 
144 See Section 58 of the Tanzania Forest Act, Act No 7 of 2004 
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corporations in pirating the TK, and the nature of the stakeholders where we have the 
giant institutions and the local society, which has low bargaining power.145
 
The Act and its regulations also has some weakness in the sense that it does not set the 
minimum benefit sharing to the local societies or individuals who might have any 
contribution in any medicinal discoveries in the forest. This is in relation to the fact that 
the local societies or individuals are always being marginalized and oppressed by the 
other stakeholders in the bio-prospecting agreements due to their low bargaining power. 
 
 
4.2.2.5 Protection through Patent Registration 
As pointed before Tanzania is a member of ARIPO, through this organization all member 
states are governed through same requirements in patent registration. Therefore in any 
application for patent registrations in Tanzania the following requirements have to be 
fulfilled. Such requirements are; 
 
“A patent application shall: 
i)  identify the applicant; 
ii) contain, as prescribed, a description of the invention, a claim or claims, 
a drawing or drawings, where necessary and an abstract; 
iii) designate the Contracting States for which the patent is requested to be 
granted; 
iv) be subject to the payment of the prescribed fees.146” 
 
As the requirements seen from above there is no emphasis on the disclosure of genetic 
materials that are used in the subject matter of the patent. Also, the protocol is silent on 
                                                 
145 As seen from the previous chapters, (chapter 2 pg 26) western pharmaceutical corporations come under 
the cover of tourism, they may also stay with the local society studying their ways of life, ultimately they 
take the knowledge for their own use  
146 See, Article 3 (1) of the Harare Protocol 
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the issue of proof of benefit sharing agreement between the users and holders of TK in its 
member states or any other stakeholders.  
 
It can also be observed that, the local societies are not protected against the giant 
stakeholders by any provision that would have set a minimum benefit sharing in any 
event of such agreement. These requirements would reflect the true picture of the 
protection of TK and equal and fair benefit sharing between the stakeholders and the 
local societies in Tanzania. 
 
 
4.3 CONCLUSION 
Having in mind the complexities as discussed in chapter three, it is obvious that the local 
societies in Tanzania and other member sates of ARIPO, needs to be protected once their 
TK is being used. Comparatively, the South African regulations dealing with access, use 
and benefit sharing on the genetic resources and TK are supporting each other hence 
assuring full protection if at all the enforcement will not be ignored. Tanzania has a lot to 
learn from the South African development in the law and the institutions dealing with the 
genetic resources and TK as seen above. 
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 CHAPTER FIVE 
 
5.0 OBSERVATIONS, RECOMMENDATIONS AND CONCLUSION 
 
5.1 Observations 
This work witnessed existence of loopholes in both international and domestic IPR 
regulations governing the protection of TKB. As has already been seen, the 
international regulations are still biased towards the western knowledge while 
according no recognition to TK at the multilateral organization. In domestic 
regulations, loopholes are found in the research institutions, which have neither 
regulations nor guidelines on the amount to be transferred to other research 
institutions abroad. 
 
Also, this work witnessed the local societies receiving little or no attention 
concerning what is going to be their benefit in any bio-prospecting agreements with 
the economically giant western corporations. 
 
Further observations regard to the criteria used (guidelines) in entering into the bio-
prospecting agreement. This research witnessed the absence of set guidelines of 
criteria to be referred when entering into such agreements with other stakeholders. It 
is left to the discretion of the   negotiating officers to decide what should be given to 
the state and the local society involved in the deal. 
 
The other observation is the incomparability existing between the regulations dealing 
with the protection of genetic resources and TKB and the regulations dealing with 
patentability. This work found that to some extent the regulations in protection of 
genetic resources and associated TKB are tight while those dealing with patentability 
are loose. This is proved due to the fact that the protection granted in the Forest Act, 
the Traditional and Alternative Medicines Act, and the National environment Policy 
is not reflected in the Patent Act. 
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From the above observation it is obvious that if a person will be able to pirate the 
genetic resources and associated TKB in our country and advance the same into a 
drug, he can apply for patent protection in our country as well. This will in turn result 
to the injustices that this work intended to address and avoid them in local societies in 
Africa.147
 
Moreover, this work observed that there is no single established institution to regulate 
the access and use of biodiversity and associated TK in Tanzania. There are a number 
of authorities regulating issues of biodiversity; these include the National Research 
Council, which deals with the registration and licensing148, and the Director of 
Forests, who deals with the research permit in the forests.149  
 
The director of forest also has power to appoint licensing and registration officers,150 
at the same time the Act, allows research in medicinal plants as among other activities 
to be carried in the forests.151 This shows the likelihood of having the registration, 
licensing and permit being issued by the office of the director of forests, hence 
disregarding the provision of the draft regulations. There need be a reconciliation of 
these two regulations to avoid unnecessary clashes in the law and thus making it easy 
to implement. 
 
 
 
 
 
                                                 
147 For detailed discussion of the injustices that could occur due to the weakness of these regulations, see 
chapter two, pg 21. 
148 See, regulation 22(1) &(2) of the proposed Draft of the Traditional and Alternative Medicines 
(Regulation of Materia Medica) Regulations 2007 
  
149See section 49 of the Forest Act 2004 
150 See section 6(3) of the Forest Act 2004 
 
151 See section 49 (c ) of the Forest Act 2004 
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5.2 RECOMMENDATIONS 
5.2.1 Recommendations on the International regulations. 
 
That the international regulations need to be amended to reflect the balance of interest 
between the western and the African local knowledge so as allow TK be recognized 
at the multilateral level. This can be achieved having the TRIPS Agreement amended 
to contain requirements like; proof of benefit sharing agreement not below a certain 
fixed percentage as the council for ministers will deem fit, proof of prior informed 
consent of the holders of genetic resources and TK, in any inventions which involve 
TK. 
 
That these amendments need to be done within the multilateral sphere and not under 
the UN initiatives as it will jeopardize the position of the developing countries in 
Trade negotiations. It should form part and parcel of the mandatory agreements of the 
WTO rules so as to assure easy enforcement of these rules. 
 
5.2.2 Recommendations on the domestic regulations 
That, there should be regulations or guidelines to limit the extent of the genetic 
extract to be transferred to other research institutions abroad. The regulation my limit 
this by inserting a condition that if the abroad researcher will need amount of genetic 
extract beyond a certain fixed quantity, then the researchers has to establish their 
research centre in our country and enter into joint venture or understudy with our 
local researchers. 
That there should be special regulations to safeguard the interest of the local societies 
or individuals in bio-prospecting agreements to assure their benefits are not 
fraudulently taken by the users of TKB. Establishing minimum standards of what 
should be their financial benefit in these agreements can achieve this. This minimum 
standard can be in terms of fixed percentage of the general benefit to be accrued out 
of the output of the research basing on the TK given by the local society or individual 
 
66 
That there should be guidelines that shall direct the negotiating officers in all the bio-
prospecting agreement on how to negotiate for the benefits of the local societies and 
other stake holders involved in such agreements.  This will avoid the likely hood of 
having the local society’s rights being jeopardized by the giant research institutions 
who are mostly the users of TK.  
 
These guidelines must exist in these institutions dealing with biodiversity rather than 
operating by the discretion of the negotiators. Their discretions should be guided by 
the existing guidelines set by the National Research Council, for the interests of the 
nation, and other stakeholders associated like the local societies/individual and the 
research institutions. 
 
That, there should be compatibility between the regulations governing access and use 
of biodiversity and the regulations dealing with patentability of innovations arising 
out of use of biodiversity. The Harare Protocol and Tanzania Patent Act need to be 
amended to include requirements such as those reflected in the South African Patent 
Act152
 
Recognition local provisional patent to TK to local African societies, which can not 
invest or research to come up with a well proved scientific formula on a number of 
traditional medicines. It can simply be granted by a mere description by the 
traditional healers to the appointed officials, of the type of the herb and how is it used 
in offering treatments.  This will also provide a basis of development in research by 
Universities in the developing world as well as developed world. 
 
Also, petty patents will allow for protections similar to those of patents, but for 
knowledge consisting of a less-detailed inventive step. Thus, the local societies must 
insist on the need to enact laws which provide for such provisions so as to be 
protected by their local legislations. 
 
                                                 
152 For more details see chapter four, pg 4. 
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5.3 CONCLUSION 
Conclusively, it can be argued that the local societies need to be protected through both, 
the local and the international IPR regulations.  As seen from the above findings, the 
protection offered to the local societies is not sufficient to provide the society with the 
full enjoyment (benefits) of their TK. 
 
The International Regulations are still biased towards Western knowledge and thus 
ignore the recognition of the local knowledge. This will still have negative implications 
in African local societies and their TK. However, as shown above if the local regulations 
in the African local societies will be strict in protecting TK, it will assure benefit sharing 
in between the user and the provider of TK.   
 
It is the humble submission of the researcher that the local regulations need to be strictly 
aimed at protecting genetic resources and associated TK. This will help, firstly, to reduce 
the rate of bio-piracy in African local societies and secondly, to assure sustainable use of 
the genetic resources and associated TK, thirdly, to assure equal and fair benefit sharing 
arising from the use of the local societies’ knowledge in the current medical scientific 
discoveries. 
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ANNEXURE A. 
AFRICAN COUNTRY'S SIGNATORIES TO THE UNITED NATIONS 
CONVENTION ON BILOGICAL DIVERSITY. 
A total of 39 countries in Africa are signatories to the CBD Convention as here under 
listed:  (http://www.biodiv.org/biosafety/signinglist.aspx?sts=rtf&ord=dt last accessed on 
13th February 2007) 
1) Algeria, 
2) Benin,  
3) Botswana,  
4) Burkina Faso,  
5) Cameroon,  
6) Cape Verde,  
7) Chad,  
8) Congo,  
9) Democratic Republic of the Congo,  
10)  Djibouti,  
11)  Egypt,  
12)  Eritrea,  
13)  Ethiopia,  
14)  Gambia, 
15)  Ghana, 
16)  Kenya,  
17)  Lesotho,  
18)  Liberia, 
19)  Libyan Arab Jamahiriya,  
20)  Madagascar,  
21)  Mali,  
22)  Mauritania,  
23)  Mauritius,  
24)  Mozambique,  
25)  Namibia,  
26)  Niger,  
27)  Nigeria, 
28)  Rwanda,  
29)  Senegal,  
30)  Seychelles, 
31)  South Africa,  
32)  Sudan, 
33)  Swaziland, 
34)   Togo, 
35)   Tunisia, 
36)   Uganda, 
37)   United Republic of Tanzania,  
38)   Zambia, 
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39)  Zimbabwe 
Member states of Harare Protocol 
 
States       Date on which State became 
party to the Protocol 
 
Botswana ………………………………….……………… May 6, 1985 
The Gambia ………………………………………………. January 16, 1986 
Ghana …………………………………………….……….. April 25, 1984 
Kenya ………………………………….………………….. October 24, 1984 
Lesotho …………………………………………………… October 23, 1987 
Malawi ……………………………….……….……………. April 25, 1984 
Mozambique …………..…………………..……………… May 8, 2000 
Namibia ……………………………………….…………… April 23, 2004 
Sierra Leone …………………………….………………… February 25, 1999 
Sudan …………………………….….…….……………….. April 25, 1984 
Swaziland ……………………………….………………… March 17, 1988 
Uganda ………………………………….………………… April 25, 1984 
United Republic of Tanzania ……………...……………… September 1, 1999 
Zambia ………………….………………………………… February 26, 1986 
Zimbabwe …………………………….…………………… April 25, 1984 
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  ANNEXURE C 
 
REQUEST FOR ACCADEMIC ASSISTANCE 
 
Dear Madam/Sir  
 
I am a student of UWC in the faculty of law. Currently I am doing my research in 
International Economic Law.   
 
I am kindly requesting your office to assist me in my research by filling in the 
questionnaires attached with this letter.   
 
Also, with this letter I enclose an identification letter from my faculty, for brief 
information about my research see below. 
 
ATTACHED HERE WITH ARE THE QUESTIONAIRES OF MY RESEARCH. 
 
 BENEFIT SHARING FROM TRADITIONAL KNOWLEDGE AND 
INTELLECTUAL PROPEERTY RIGHTS IN AFRICA: AN ANALYSIS OF 
INTERNATIONAL REGULATIONS 
 
This research is being done due to the wide spread of Bio-piracy in African local 
societies by the developed countries. It is the same developed countries that resist against 
inclusion of disclosure of origin of the genetic resources in the TRIPS Agreement.  
 
This makes the international intellectual property regulations biased towards the western 
scientific knowledge while according no recognition to Traditional Knowledge (TK). 
This has effects in increase of spread of bio-piracy and denial of local society of any 
proceeds out of their TK. 
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The main aim of this research is to provide recommendations in African local society on 
the need to have domestic regulations (to protect their TK) on access and use of the 
genetic resources and associated TK.  This will help these societies in regulating their TK 
and thus derive benefit out of it whenever used. Ultimately, if the recommendations be 
adopted will combat the problem of wide spread of bio-piracy. 
 
 
Your answers which, I will be glad to receive at the end of the next week; (16th March 
2007) will be kept confidential. Also, I will use them only for the purpose stated above.  
 
Your contribution will also be acknowledged at the end of my research, prove of which 
will be evidenced upon receipt of the electronic copy of my final paper. 
 
 
I pass my thanks in advance for your cooperation. 
 
Yours Faithful 
  
Ombella John S. 
LL.M International Trade and Investment Law in Africa 
University of the Western Cape 
E-mail address: ombella@gmail.com/ombellla@yahoo.co.uk
Mobile No. +255713227298 
 
 
QUESTIONAIRES: 
 
What are the criteria used by the researchers in identifying the plant with medicinal value 
in their research? 
? Do they consult the traditional society for information?………… 
? Do they just troubleshoot in ascertaining the plant!…………. 
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 1. How is the local community involved in the benefit of the research in your 
Institutions? 
…………………………………………………………………………………………
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
 
2. Does your institution distinguish between the herbal medicines that its knowledge 
is already in public domain and the one, which is still held by an 
individual?..................................................................................................................
........................................................... 
 
3.  What is the approach and participation in the last circumstance! 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
……………………………………………………………………………………….. 
 
 
 
4. Is there a set regulation or policy regulating the amount of genetic materials to be 
transferred/ exported for research abroad in other Universities!  
…………………………………………………………………………………………
…………………………………………………………………………………………
………………………………………………………………………………………….. 
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? What about for commercial purposes! What are the differences between the two? 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
……………………………………………………………………………………….. 
 
 
? Are there any plan going on or in future to develop capacity to prepare medical 
plants extracts for sale on the World Market? Or is there any link between this 
trade and conservation and community development? 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
 
 
? What are the main factors taken into considerations when granting a large extract 
to a person for commercial purposes? 
? Do you have a mechanism to insist on mandatory value-added processing 
in your own country?…………………………………….. 
? Do you negotiate supply contracts?………………………… 
? Do you just negotiate royalties or ensure sustainable harvesting?………… 
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4. What are your ideas on the contribution of the Protection of Traditional Knowledge 
and the increase of Investment in African Countries? 
? Do you insist on mandatory value-added processing in your 
country?………………………………………………….. 
? Do you insist on the need to have the whole of the industries 
dealing with the production of the same drugs, or on the basis of 
local company to produce the same under license, or establishing .a 
subsidiary Industry in the country of origin of these 
genetic?……………………………………………… 
 
5. Are the contacts of benefit sharing forming part of public documents in your 
jurisdiction or they are just a private documents held in between the concerned 
community and the foreign companies which access the genetic resources and 
associated knowledge? 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
……………………………………………………………………………………….. 
 
 
6. Do you have a set of minimum benefit sharing to grant to the local community 
that has any contribution in any of your medicinal discoveries? 
………………………………………………………………………………….. 
…………………………………………………………………………………… 
 
Any other comments or contributions don’t hesitate to write on the next page please! 
 
Name………………………………… 
Title……………………………………. 
Address ………………………………….. 
 
75 
 ANNEXURE D 
GOVERNMENT NOTICE NO .........................published on ....... 
THE TRADITIONAL AND ALTERNATIVE MEDICINES                   
ACT, 2002 
(NO 23 OF 2002) 
REGULATIONS 
(Made Under Section 55 (I) and (2) 
THE TRADITIONAL AND 
ALTERNATIVE MEDICINES (REGISTRATION 
OF MATERIA MEDICA) REGULATIONS, 2007 
PART I  
PLERIMINARY PROVISIONS  
I. The Regulation shall be cited as the Traditional and Alternative Medicines (Materia 
Medica)Regulation 2007. 
2. (1) These Regulations shall apply to all traditional and alternative medicines and related 
products  
(2) In case of proceedings before the Council, these Regulations shall apply to all traditional and 
alternative health practitioners and enrolled aides irrespective of whether or not any such 
traditional or alternative health practitioner is registered.  
3. In these Regulations unless the context otherwise requires:” Act "means 
the Traditional and Alternative Medicines, Act, 2002;  
"Alternative Health Practitioner" means a person formally trained and has acquired knowledge, 
skills and competence in alternative medicine practices and disciplines as recognized 
international   
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"Category I Materia Mcdica" means extemporaneous medicines custom prepared by the health 
practitioner for the patient attending his/her Ki/inge:  
"Category 2 Materia  Medica" means traditional medicines with overwhelming ethnomedical 
information in the communities in which they are used. Scientific validations on their quality, 
safety and efficacy have been documented and therefore such products can be industrially 
manufactured and circulated in commerce;  
"Category 3 Materia Medica" means new chemical entities that have been isolated from 
medicinal plants or preparations and on which the standard pharmaceutical research has been 
carried out. Such compounds can now be treated as conventional pharmaceutical products and 
thus regulated and commercialized as such,  
"Category 4 Matcria Mcdica" means traditional medicines remedy that has been impol1cd from 
outside the WHO African Region. Since there is no known local African ethnomedical evidence 
available on them. they will require appropriate~ investigation on their sources. quality. safety 
and efficacy,  
"Category 5 Materia medica" means" alternative medicine remedy tl1al includes methods or 
processes used or curing or any preparations derived from plants. animals or mineral products 
that mayor may not contain chemical characteristics of  such substances from which its derived 
that have the therapeutic effect in the intended individual and preparation of such a remedy 
follows the systems of alternative medical and discipline employed  
"composition" in relation to materia m~dica means the ingredients which it consists. proportions 
and quantities in which those ingredients are contained  
 
"container" in relation to materia medica regulated under this regulation, means a bottle, jar, 
box, packet, sachet, pumpkin guard or other acceptable instrument used to keep materia 
medica for human or animal use  
"Council" means the Traditional and Alternative Health Practice Council 
established under section 4 of the Act;  
"devices" means  
"distributor" means 
 Killinge" means a basic traditional health facility which may provide consultancy and 
outpatient services;  
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"Label" means any tag, mark, pictorial or other descriptive matter, written, printed, 
marked or attached to a container of any materia medica or devices "leaflet" means 
and includes any written information related to materia medica or u<.:vit:<.:s  
Matria medica means natural resources  of medicinal value , semi processed 
or processed  and finished for human healthy, animal or agriculture.  
;'Minister" means the Minister for the time being responsible for health 
matters;  
" owner" means any person legally registered as the owner of materia medica and or 
manufacturing facility for materia medica  
"Raw or semi finished matcria mcdica" means materia medica used as raw 
materials for preparation, processing and or manufacturing of traditional and 
alternative medicines;  
 
"traditional health practitioner" means a person who is recognized by the community in which 
he live as competent to provide health care by using plants. animals, mineral substances and 
other methods based on social, cultural and religious background as well as on the knowledge, 
attitudes and beliefs that are prevalent in the community regarding physical, mental and social 
well being and cause of disease and disability 
 
PART II  
CONSERVATION AND MANAGEMENT  
(I) The Council shall establish and maintain National medicinal plants data bank or 
compendium and prepare, keep and maintain a list of all medicinal plants;  
(2) No reason other than a registered practitioner: enrolled aide and local researcher shall be 
allowed to harvest medicinal plants in:  
 ••  quantity more than those consumed by family/household;  
 ••  quantities more than those required for his n practices per month  
 ••  quantities for the purposes of transpol1ing be)'and his district without the permit  
from the council  
 ••  no foreign person shall be al lowed to harvest medicinal plants for an) purposes  
without prior written permit from the Council  
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(3) No person shall sell raw or semi finished materia medica unless s/he is registered with the 
Council 
 
5. (I) The Council shall issue guidelines prescribing the manner and nature of 
handling and transportation of materia medica and related materials;  
(2) The materia medica shall be handled and transported in such a manner as shall 
observe safety. potency and quality of the raw materia medica;  
(3) Materia medica shall be stored in such a manner as shall ensure safety. potency. 
quality and compliance of the guidelines as shall be issued by the Council;  
(4) The materia medica shall be kept in a special room or area designed for that purpose 
and the room so designed shall be clean. dry and well ventilated to avoid moisture, 
overheating and pests;  
(5) The Council shall issue guidelines prescribing shelf life for every medicinal plants. 
materia medica and any other related products;  
(6) No materia medica shall be kept and stored for a period more than their shelf life  
6. The Council shall conduct regular inspection to ensure compliance in respect of 
harvesting, handling. Storage, and storage facilities of materia medica and any other 
related products: 
 
PART III  
PREPARATION AND PROCESSING OF MATERIA MEDICA  
.( I) The Council shall subject to these Regulations have power to categories various 
types of materia medica and related products; 
(2) Types of materia medica and related products shall include;  
(a)  Category I Materia Medica 
(b)  Category 2 Materia Medica 
(c)  Category 3 Materia Medica 
(d)  Category 4 Materia Medica 
(e)  Category 5 Materia Medica 
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 8. ( I) Category I Materia Medica shall be extemporaneous medicines custom prepared 
by the health practitioner for the patient attending his/her Kilinge;  
(2) Category 2 Materia Medica shall be well known traditional medicines with 
overwhelming ethno-medical information in the communities in which they are used and 
scientific validations on its quality, safety and efficacy have been documented and 
therefore such products can be industrially manufactured and circulated for commercial 
purpose:  
(3) Category 3 Materia Medica shall be new chemical entities that have been isolated 
from medicinal plant or preparations and on which their standard pharmaceutical 
research has been carried out such compounds can now be treated as conventional 
pharmaceutical products and thus regulated by appropriate authority and commercialized 
under TFDA Act 2003;   
(4) Category 4 Materia Medica shall be traditional medicines remedy that ha\'c been 
prepared from materials or finished products imported from outside the WHO African 
Region,  
(5) Category 5 Materia Medica shall be alternative medicines remedy that includes 
methods or processes used for curing or any preparations derived from plants. animals or 
mineral products that mayor may not contain chemical characteristics of such substances 
from which its derived that have the therapeutic effect in the intended individual and 
preparation of such a remedy follow the systems of alternative medicine: and discipline 
employed  
(6) Category 2 and 5 of materia medica. the information on the label should include: 
(a) name and particulars of the medicine or remedy 
(b) ingredient used;  
     (c) dosage form;  ,  
     (d) the name of manufacturer; and  
   (e) batch number  
(7) Raw or semi finished material medica shall be prepared, labeled and packed by 
practitioners in containers either modern or traditional to ensure safety, potency and 
quality;  
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 9. The Council shall issue guidelines prescribing matters related to labeling, prescribing and 
dispensing of materia medica;  
10. For the purposes of ensuring Consistent  quality of preparation process and the product, 
every materia medica preparations, procedures and mixtures of a finished product shall be 
documented;  
 
 
PART IV 
REGISTRATION OF       
MATERIA MEDICA 
II. Save for extemporaneous materi.medica, all materia medica shall not be used any manner 
whatsoever unless registered by the Council;  
12. ( I) A person who is desirous of his materia medica to he registered by the Council 
shall fill the application form  and submit to the council   
(2) The application forms shall be as set in the First Schedule to these Regulations; (3) 
The application made under sub-regulation (I) shall be accompanied by:-  
(a) a certified copy of a certificate of registration of a practitioner;  
(b) a certificate of toxicological analysis and or tests;  
(c) statement as to the assessment of efficacy;  
(d) statement as to the clinical evaluation;  
(4) Application for Registration of materia medica shall be approved by the Council subject 
to payment of fees as prescribed by the Council;  
(5) The Council shall as quickly as practicable and after having been satisfied as to safety, 
potency. quality and compliance to these Regulations register the material 
 
13. (I) The Council may cancel the registration of a materia medica and inform the owner 
or proprietor of the cancelled materia medica:-  
(a) if the materia medica is found to be toxic or has acute adverse reactions (b) 
if the materia medica is among the prohibited substance  
(c) if the materia medica after due research and tests is proved to have failed to cure the 
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intended diseases  
(2) The Council shall publish in the Government Gazette cancellations of any materia 
medica  
14. Person aggrieved by the decision of the Council under regulation 13 (2) of these 
regulations may appea1 to the Minister  
15,The Council shall keep and maintain a register of all registered materia medica and  
 Publish the same in the Government gazette at least once per annum     
 
PART V  
MARKETING 
16. (I) No advertisement for materia medica shall be made public unless scrutinized and 
approved by the Council;  
(2) The Council shall issue PERMIT for ADVERTISING the registered materia medica after 
being satisfied that the provisions of these Regulations have been complied with; 
 
(3) Any person who is desirous of advertising his materia medica shall apply for 
permit to the Council;  
(4) The Council shall issue the advertising permit after payment of a fee as prescribed 
by the Council;  
(5) Save for the producer of the materia medica, any person who intends to distribute  
 materia medica for sale shall apply and get a permit from the Council;    
17. (I) No person shall undertake large scale production and marketing of materia 
medica unless he is registered by the Council;  
(2) Application for Registration 'of large scale production and marketing of materia 
medica shall be in the form as provided in the schedules to these regulations;  
(3) The Council shall issue the permit after payment of fees as prescribed by the 
Council:  
  
82 
18. (I) No person shall export and or import materia medica unless he is registered as 
such by the Council:  
rf} Application for  Registration shall be in the form as may be set out by the Council; 
 (3) The Council upon liaising with relevant authorities shall issue export and import  
permit after payment of the export and import fees as shall be prescribed by the 
Council:  
19. The Council may revoke or cancel any such permit where the holder of the permit 
contravenes any of the provisions of Regulations on marketing;  
20. Any person aggrieved by the decision of the Council under regulation 16. 17, 18 
and 19 of these regulations may appeal to the Minister;  
21. The Council shall keep and maintain a register of exporters. importers and 
distributors of materia medica and related products;  
 
PART VI 
RESEARCH  
22. (I) Every application for registration and license to conduct a research shall be 
submitted to the Council  
(2) No person shall conduct research on materia medica unless he is recognized by the 
National Institute for Medical Research;  
(3) Where an applicant is non citizen the application shall abide by rules and 
regulations prepared by National Institute for Medical Research, Commission for Science 
and Technology and Tanzania Food and Drug Authority. However, the Council may 
advise to stop research if it contravenes with these regulations;  
(4) No person shall conduct research on matters other than those indicated in the license ; . 
 (5) Any research permits application on materia medica involving or in collaboration  
with Traditional and Alternative Health Practitioners shall be accompanied by a  
memorandum of understanding;  
(6) The Council I shall satisfy itself f that the memorandum of understanding safeguards 
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the interests of Traditional and Alternative  Health Practitioners, the Council and the 
Country;  
(7) The Council may reject to offer the research permit if it is not satisfied with 
the memorandum of understanding;  
(8) There shall be a representative from the Council and Traditional Medicine Section 
in the Directorate of Hospital Services to the National Ethical Clearances Committee 
under the National Institute for Medical Research;  
 
(9) There shall be a copy to the Council of the Council of the ethical clearance for all research 
related to materia medica;  
(10) Every application for research permit shall be accompanied by a fee prescribed by the 
Council;  
(11) The Council shall keep and maintain a register/data base of research on materia medica;  
23. The Council shall have powers to monitor all researches on materia medica in the 
Country: in this case Tanzania mainland 
 
PART VII  
PROTECTION OF INFORMATION 
The Council shall not disclose to third part information related to the Council  
(a) Botanical and biological composition of the materia medica and related products; 
(b) efficacy and active ingredients; 
(c)   chemical composition; 
(d)  methodology of preparation  or preparation and processing of materia medica; 
(e)   purity test and clinical evaluation  
(f)  information related to healing and treatment ;  
Unless agreed by the owner of the registered materia medica  
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 25 (I) The Council shall protect the intellectual property rights of the founders and owners 
of the registered materia medica:  
(2) No person other than the owner shall prepare, process, sell and or advertise for sale any 
registered materia medica unless he is authorized in writing by the owner;  
(3) No person shall conduct research on any processed materia medica without prior written 
consent of the owners:  
 
 
P ART VIII  
OFFENCES AND PENALTIES  
 
26 (I) Any person who intentionally gives false information to the Council as [0 safety, 
potency and quality of the materia medica and other related material commits an offence and on 
conviction be liable to a fine not exceeding five hundred thousands shillings or to imprisonment 
for a term not exceeding six months or both;  
 (2) Any person who harvests. prepares or processes any materia medica without being ~ 
registered by the Council commits an offence and on conviction be liable to a fine not exceeding 
five million shillings or to imprisonment for a term not exceeding three years or both;  
(3) Any person who harvests quantities more than those consumed by family/household without 
the permit from the council commits an offence and 0:1 conviction be liable to a fine not 
exceeding one hundred thousands shillings or to imprisonment for a term not exceeding six 
months or both:  
(4) Any person who harvests quantities more than those required for his/her own practices  per 
month without the permit  from the council commits an offence and on conviction be liable to a 
fine not exceeding two hundred thousands shillings or to imprisonment for a term not exceeding 
twelve months or both;  
(5) Any person who harvests quantities 1'01' the purposes of transporting beyond his/her district 
without the permit from the council commits an offence and on conviction be liable to a fine not 
exceeding five hundred thousands shillings or to imprisonment for a term  not exceeding two 
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years or both.  
 
(6) Any foreign person who harvests medicinal plants for any purposes without prior written 
permit from the Council commits an offence and on conviction be liable to a fine not exceeding 
five millions or to imprisonment for a term not exceeding five years or both;  
(7) Any person who advertises any materia medica without the approval of the Council  
 ) commits an offence and is liable on conviction to a fine not exceeding three hundred thousands 
shillings or to imprisonment for a term not exceeding six months or both:  
(8) Any person who advertises  
(a) any counterfeit materia medica,  
(b) sub-standardized materia medica,  
(c) false label materia medica or  
(d) contravenes any other provision of these Regulations,  
commits an offence and is liable on conviction to a fine not exceeding three hundred thousands 
shillings or to imprisonment for a term not exceeding six months or both;  
(9) Any person who sells or exposes for sale any un-registered materia medica or materia medica 
whose registration has been cancelled shall commit an offence and liable to on conviction to a 
fine not exceeding five hundred thousand shillings or toimprisonment  for a term not exceeding 
one year or both.  
(I O) Any person who contravenes the intellectual property rights of the of the founder and the 
owner  of the registerd nmateria medica, commits an offence and on conviction shall  be liable to 
fine not exceeding five million shillings or imprisonment for a term not exceeding three years or 
both.    
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